Regulation	O
of	O
cell-type-specific	O
interleukin-2	B-protein
receptor	I-protein
alpha-chain	I-protein
gene	O
expression	O
:	O
potential	O
role	O
of	O
physical	O
interactions	O
between	O
Elf-1	B-protein
,	O
HMG-I	B-protein
(	I-protein
Y	I-protein
)	I-protein
,	O
and	O
NF-kappa	B-protein
B	I-protein
family	I-protein
proteins	I-protein
.	O

The	O
interleukin	B-DNA
2	I-DNA
receptor	I-DNA
alpha-chain	I-DNA
(	I-DNA
IL-2R	I-DNA
alpha	I-DNA
)	I-DNA
gene	I-DNA
is	O
rapidly	O
and	O
potently	O
induced	O
in	O
T	B-cell_type
cells	I-cell_type
in	O
response	O
to	O
mitogenic	O
stimuli	O
.	O

Previously	O
,	O
an	O
inducible	B-DNA
enhancer	I-DNA
between	O
nucleotides	B-DNA
-299	I-DNA
and	I-DNA
-228	I-DNA
that	O
contains	O
NF-kappa	B-DNA
B	I-DNA
and	I-DNA
CArG	I-DNA
motifs	I-DNA
was	O
identified	O
.	O

We	O
now	O
report	O
the	O
characterization	O
of	O
a	O
second	O
essential	B-DNA
positive	I-DNA
regulatory	I-DNA
element	I-DNA
located	O
between	O
nucleotides	B-DNA
-137	I-DNA
and	I-DNA
-64	I-DNA
that	O
binds	O
Elf-1	B-protein
and	O
HMG-I	B-protein
(	I-protein
Y	I-protein
)	I-protein
.	O

This	O
element	O
had	O
maximal	O
activity	O
in	O
lymphoid	B-cell_type
cells	I-cell_type
,	O
paralleling	O
the	O
cell	O
type	O
specificity	O
of	O
Elf-1	B-protein
expression	O
.	O

Transcription	O
from	O
the	O
IL-2R	B-DNA
alpha	I-DNA
promoter	I-DNA
was	O
inhibited	O
when	O
either	O
the	O
Elf-1	B-DNA
or	I-DNA
the	I-DNA
HMG-I	I-DNA
(	I-DNA
Y	I-DNA
)	I-DNA
binding	I-DNA
site	I-DNA
was	O
mutated	O
.	O

Coexpression	O
of	O
both	O
proteins	O
activated	O
transcription	O
of	O
the	O
-137	B-DNA
to	I-DNA
-64	I-DNA
element	I-DNA
in	O
COS-7	B-cell_line
cells	I-cell_line
.	O

Elf-1	B-protein
physically	O
associated	O
with	O
HMG-I	B-protein
and	O
with	O
NF-kappa	B-protein
B	I-protein
p50	B-protein
and	O
c-Rel	B-protein
in	O
vitro	O
,	O
suggesting	O
that	O
protein-protein	O
interactions	O
might	O
functionally	O
coordinate	O
the	O
actions	O
of	O
the	O
upstream	B-DNA
and	I-DNA
downstream	I-DNA
positive	I-DNA
regulatory	I-DNA
elements	I-DNA
.	O

This	O
is	O
the	O
first	O
report	O
of	O
a	O
physical	O
interaction	O
between	O
an	O
Ets	O
family	O
member	O
and	O
NF-kappa	B-protein
B	I-protein
family	I-protein
proteins	I-protein
.	O

These	O
findings	O
provide	O
significant	O
new	O
insights	O
into	O
the	O
protein-protein	O
and	O
protein-DNA	O
interactions	O
that	O
regulate	O
cell-type-specific	O
and	O
inducible	O
IL-2R	B-protein
alpha	I-protein
gene	O
expression	O
and	O
also	O
have	O
implications	O
for	O
other	O
genes	O
regulated	O
by	O
Elf-1	B-protein
and	O
NF-kappa	B-protein
B	I-protein
family	I-protein
proteins	I-protein
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
Mar	NULL
.	NULL

1995	NULL
,	NULL
p.	NULL
1786-1796	NULL
0270-7306/95/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

15	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Regulation	NULL
of	NULL
Cell-Type-Specific	NULL
Interleukin-2	NULL
Receptor	NULL
«	NULL
-Chain	NULL
Gene	NULL
Expression	NULL
:	NULL
Potential	NULL
Role	NULL
of	NULL
Physical	NULL
Interactions	NULL
between	NULL
Elf-1	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
Family	NULL
Proteins	NULL
SUSAN	NULL
JOHN	NULL
,	NULL
RAYMOND	NULL
B.	NULL
REEVES	NULL
,	NULL
``	NULL
JIAN-XIN	NULL
LIN	NULL
,	NULL
``	NULL
RYAN	NULL
CHILD	NULL
,	NULL
JEFFREY	NULL
M.	NULL
LEIDEN	NULL
,	NULL
``	NULL
CRAIG	NULL
B.	NULL
THOMPSON	NULL
,	NULL
*	NULL
anp	NULL
WARREN	NULL
J	NULL
.	NULL

LEONARD	NULL
'	NULL
!	NULL

'*	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Immunology	NULL
,	NULL
National	NULL
Heart	NULL
,	NULL
Lung	NULL
,	NULL
and	NULL
Blood	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
;	NULL
Departments	NULL
of	NULL
Biochemistry	NULL
and	NULL
Biophysics	NULL
and	NULL
of	NULL
Genetics	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Washington	NULL
State	NULL
University	NULL
,	NULL
Pullman	NULL
,	NULL
Washington	NULL
99164-4660	NULL
;	NULL
and	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Pathology®	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
and	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
of	NULL
Molecular	NULL
Genetics	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
``	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
Illinois	NULL
60637-5420	NULL
Received	NULL
29	NULL
September	NULL
1994/Returned	NULL
for	NULL
modification	NULL
16	NULL
November	NULL
1994/Accepted	NULL
21	NULL
December	NULL
1994	NULL
The	NULL
interleukin	NULL
2	NULL
receptor	NULL
-chain	NULL
(	NULL
IL-2Ra	NULL
)	NULL
gene	NULL
is	NULL
rapidly	NULL
and	NULL
potently	NULL
induced	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
mitogenic	NULL
stimuli	NULL
.	NULL

Previously	NULL
,	NULL
an	NULL
inducible	NULL
enhancer	NULL
between	NULL
nucleotides	NULL
-299	NULL
and	NULL
-228	NULL
that	NULL
contains	NULL
NF-KB	NULL
and	NULL
CArG	NULL
motifs	NULL
was	NULL
identified	NULL
.	NULL

We	NULL
now	NULL
report	NULL
the	NULL
characterization	NULL
of	NULL
a	NULL
second	NULL
essential	NULL
positive	NULL
regulatory	NULL
element	NULL
located	NULL
between	NULL
nucleotides	NULL
-137	NULL
and	NULL
-64	NULL
that	NULL
binds	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
.	NULL

This	NULL
element	NULL
had	NULL
maximal	NULL
activity	NULL
in	NULL
lymphoid	NULL
cells	NULL
,	NULL
paralleling	NULL
the	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
Elf-1	NULL
expression	NULL
.	NULL

Transcription	NULL
from	NULL
the	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
was	NULL
inhibited	NULL
when	NULL
either	NULL
the	NULL
Elf-1	NULL
or	NULL
the	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
site	NULL
was	NULL
mutated	NULL
.	NULL

Coexpression	NULL
of	NULL
both	NULL
proteins	NULL
activated	NULL
transcription	NULL
of	NULL
the	NULL
-137	NULL
to	NULL
-64	NULL
element	NULL
in	NULL
COS-7	NULL
cells	NULL
.	NULL

Elf-1	NULL
physically	NULL
associated	NULL
with	NULL
HMG-I	NULL
and	NULL
with	NULL
p50	NULL
and	NULL
c-Rel	NULL
in	NULL
vitro	NULL
,	NULL
suggesting	NULL
that	NULL
protein-protein	NULL
interactions	NULL
might	NULL
functionally	NULL
coordinate	NULL
the	NULL
actions	NULL
of	NULL
the	NULL
upstream	NULL
and	NULL
downstream	NULL
positive	NULL
regulatory	NULL
elements	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
report	NULL
of	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
an	NULL
Ets	NULL
family	NULL
member	NULL
and	NULL
NF-KB	NULL
family	NULL
proteins	NULL
.	NULL

These	NULL
findings	NULL
provide	NULL
significant	NULL
new	NULL
insights	NULL
into	NULL
the	NULL
protein-protein	NULL
and	NULL
protein-DNA	NULL
interactions	NULL
that	NULL
regulate	NULL
cell-type-specific	NULL
and	NULL
inducible	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
expression	NULL
and	NULL
also	NULL
have	NULL
implications	NULL
for	NULL
other	NULL
genes	NULL
regulated	NULL
by	NULL
Elf-1	NULL
and	NULL
family	NULL
proteins	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
IL-2	NULL
receptors	NULL
(	NULL
IL-ZR	NULL
)	NULL
critically	NULL
regulates	NULL
the	NULL
magnitude	NULL
and	NULL
duration	NULL
of	NULL
the	NULL
T-cell	NULL
immune	NULL
response	NULL
(	NULL
42	NULL
,	NULL
70	NULL
)	NULL
.	NULL

Resting	NULL
T	NULL
cells	NULL
and	NULL
large	NULL
granular	NULL
lymphocytes	NULL
express	NULL
intermediate-affinity	NULL
IL-2R	NULL
,	NULL
which	NULL
consist	NULL
of	NULL
the	NULL
IL-2R	NULL
B	NULL
(	NULL
25	NULL
64	NULL
,	NULL
76	NULL
)	NULL
and	NULL
y	NULL
(	NULL
68	NULL
)	NULL
chains	NULL
.	NULL

y	NULL
is	NULL
encoded	NULL
by	NULL
the	NULL
gene	NULL
that	NULL
is	NULL
defective	NULL
in	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
(	NULL
56	NULL
)	NULL
and	NULL
is	NULL
now	NULL
referred	NULL
to	NULL
as	NULL
the	NULL
common	NULL
y	NULL
chain	NULL
(	NULL
y	NULL
,	NULL
)	NULL
,	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
its	NULL
also	NULL
being	NULL
shared	NULL
by	NULL
the	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
and	NULL
IL-15	NULL
receptors	NULL
(	NULL
21	NULL
,	NULL
32	NULL
,	NULL
33	NULL
,	NULL
55	NULL
,	NULL
62	NULL
)	NULL
.	NULL

With	NULL
cellular	NULL
activation	NULL
,	NULL
the	NULL
IL-2R	NULL
«	NULL
-chain	NULL
(	NULL
IL-2Ra	NULL
)	NULL
gene	NULL
is	NULL
induced	NULL
(	NULL
39	NULL
,	NULL
54	NULL
)	NULL
,	NULL
converting	NULL
intermediate-affinity	NULL
receptors	NULL
to	NULL
high-affinity	NULL
ones	NULL
(	NULL
42	NULL
70	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
whereas	NULL
IL-ZRB	NULL
and	NULL
y	NULL
,	NULL
,	NULL
are	NULL
essential	NULL
molecules	NULL
whose	NULL
dimerization	NULL
is	NULL
required	NULL
for	NULL
IL-2	NULL
signaling	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
,	NULL
IL-Z2Ra	NULL
expression	NULL
is	NULL
an	NULL
essential	NULL
determinant	NULL
of	NULL
the	NULL
acquisition	NULL
by	NULL
a	NULL
cell	NULL
of	NULL
full	NULL
responsiveness	NULL
to	NULL
IL-2	NULL
.	NULL

Conse-quently	NULL
,	NULL
IL-2Ra	NULL
«	NULL
transcription	NULL
is	NULL
tightly	NULL
regulated	NULL
(	NULL
reviewed	NULL
reference	NULL
38	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
is	NULL
potently	NULL
induced	NULL
within	NULL
1	NULL
h	NULL
following	NULL
mitogenic	NULL
stimulation	NULL
of	NULL
normal	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
gene	NULL
is	NULL
also	NULL
rapidly	NULL
induced	NULL
by	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
have	NULL
been	NULL
extensively	NULL
used	NULL
to	NULL
delineate	NULL
regulatory	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra	NULL
promoter	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
7	NULL
,	NULL
43	NULL
,	NULL
75	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
dem	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Immunology	NULL
,	NULL
National	NULL
Heart	NULL
,	NULL
Lung	NULL
,	NULL
and	NULL
Blood	NULL
Institute	NULL
,	NULL
Mail	NULL
Stop	NULL
1674	NULL
,	NULL
Bldg	NULL
.	NULL

10	NULL
,	NULL
Rm	NULL
.	NULL

7N262	NULL
,	NULL
9000	NULL
Rockville	NULL
Pike	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
301	NULL
)	NULL
496-0098	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
301	NULL
)	NULL
402-0971	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
wil	NULL
@	NULL
helix.nih.gov	NULL
.	NULL

1786	NULL
onstrated	NULL
that	NULL
inducible	NULL
IL-2Ra	NULL
expression	NULL
is	NULL
at	NULL
least	NULL
partially	NULL
regulated	NULL
by	NULL
a	NULL
potent	NULL
enhancer	NULL
located	NULL
between	NULL
nucleotide	NULL
positions	NULL
-299	NULL
and	NULL
-228	NULL
relative	NULL
to	NULL
the	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
44	NULL
)	NULL
,	NULL
herein	NULL
termed	NULL
positive	NULL
regulatory	NULL
region	NULL
I	NULL
(	NULL
PRRI	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

This	NULL
enhancer	NULL
contains	NULL
NF-kB	NULL
and	NULL
CArG	NULL
motifs	NULL
,	NULL
binding	NULL
sites	NULL
which	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
the	NULL
transactivator	NULL
protein	NULL
(	NULL
Tax	NULL
)	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
,	NULL
PMA	NULL
,	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
8	NULL
,	NULL
43	NULL
,	NULL
46	NULL
,	NULL
75	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
this	NULL
enhancer	NULL
,	NULL
however	NULL
,	NULL
is	NULL
not	NULL
well	NULL
conserved	NULL
in	NULL
the	NULL
murine	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
(	NULL
67	NULL
)	NULL
,	NULL
and	NULL
furthermore	NULL
,	NULL
internal	NULL
deletions	NULL
within	NULL
the	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
suggested	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
positive	NULL
regulatory	NULL
elements	NULL
more	NULL
proximal	NULL
to	NULL
the	NULL
promoter	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

We	NULL
now	NULL
report	NULL
the	NULL
characterization	NULL
of	NULL
a	NULL
transcriptional	NULL
regulatory	NULL
element	NULL
located	NULL
between	NULL
nucleotides	NULL
-137	NULL
and	NULL
-64	NULL
(	NULL
PRRII	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

This	NULL
element	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
at	NULL
least	NULL
two	NULL
DNA-binding	NULL
proteins	NULL
:	NULL
an	NULL
Ets	NULL
family	NULL
protein	NULL
,	NULL
Elf-1	NULL
(	NULL
72	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nonhistone	NULL
chromatin-associated	NULL
proteins	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
(	NULL
14	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Deletion	NULL
or	NULL
mutation	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
these	NULL
proteins	NULL
profoundly	NULL
reduced	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
tran-scription	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
upstream	NULL
enhancer	NULL
(	NULL
PRRI	NULL
)	NULL
,	NULL
and	NULL
overexpression	NULL
of	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
together	NULL
in	NULL
COS-7	NULL
cells	NULL
activated	NULL
transcription	NULL
from	NULL
PRRII	NULL
.	NULL

Elf-1	NULL
specifically	NULL
bound	NULL
to	NULL
NF-kB1	NULL
(	NULL
p50	NULL
)	NULL
and	NULL
c-Rel	NULL
in	NULL
vitro	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
protein-protein	NULL
interactions	NULL
may	NULL
mediate	NULL
the	NULL
transcriptional	NULL
coordination	NULL
between	NULL
PRRI	NULL
and	NULL
downstream	NULL
PRRII	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
PRRII	NULL
has	NULL
,	NULL
therefore	NULL
,	NULL
significantly	NULL
enhanced	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
regulation	NULL
of	NULL
the	NULL
IL-Z2Ra	NULL
gene	NULL
and	NULL
opens	NULL
up	NULL
new	NULL
avenues	NULL
for	NULL
understand	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
IL-2R	NULL
«	NULL
EXPRESSION	NULL
1787	NULL
A	NULL
POSITIVE	NULL
REGULATORY	NULL
REGIONS	NULL
PRRL	NULL
PRRILI	NULL
-472	NULL
-276	NULL
+244	NULL
137	NULL
--	NULL
-	NULL
-T	NULL
oir	NULL
22	NULL
%	NULL
NF-	NULL
«	NULL
xB	NULL
SRF	NULL
~130	NULL
-120	NULL
B	NULL
HUMAN	NULL
|	NULL
#	NULL
Coccaaicrararroréare	NULL
(	NULL
a	NULL
)	NULL
{	NULL
gCaCTTCCTATATTTGAGATGAGACAAGAGAGTOC	NULL
MA	NULL
M2	NULL
-_	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
cea	NULL
--	NULL
--	NULL
--	NULL
--	NULL
(	NULL
A	NULL
MB	NULL
__	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
ceg	NULL
--	NULL
--	NULL
--	NULL
--	NULL
(	NULL
A	NULL
)	NULL
--	NULL
--	NULL
-	NULL
MUTANTS	NULL
]	NULL
MA	NULL
=_	NULL
_	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-==	NULL
--	NULL
--	NULL
--	NULL
--	NULL
(	NULL
A	NULL
MS	NULL
__	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
MIG	NULL
=_	NULL
M7	NULL
__	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
MURINE	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
(	NULL
A	NULL
)	NULL
qg	NULL
--	NULL
--	NULL
--	NULL
--	NULL
~	NULL
--	NULL
-	NULL
AA	NULL
--	NULL
--	NULL
-	NULL
C-C	NULL
--	NULL
--	NULL
C	NULL
--	NULL
-AA	NULL
--	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
human	NULL
IL-2Ra5	NULL
'	NULL
regulatory	NULL
region	NULL
between	NULL
nucleotides	NULL
-472	NULL
and	NULL
+109	NULL
,	NULL
including	NULL
the	NULL
upstream	NULL
and	NULL
downstream	NULL
positive	NULL
regulatory	NULL
regions	NULL
(	NULL
PRRs	NULL
)	NULL
.	NULL

The	NULL
upstream	NULL
enhancer	NULL
(	NULL
PRRT	NULL
)	NULL
was	NULL
originally	NULL
defined	NULL
as	NULL
-299	NULL
to	NULL
-228	NULL
,	NULL
but	NULL
a	NULL
smaller	NULL
fragment	NULL
from	NULL
-276	NULL
to	NULL
-244	NULL
spanning	NULL
the	NULL
NF-kB	NULL
and	NULL
CArG	NULL
motifs	NULL
exhibits	NULL
similar	NULL
activity	NULL
.	NULL

SRF	NULL
can	NULL
bind	NULL
to	NULL
the	NULL
CArG	NULL
motif	NULL
in	NULL
PRRI	NULL
(	NULL
75	NULL
)	NULL
.	NULL

The	NULL
newly	NULL
identified	NULL
-137/-64	NULL
positive	NULL
regulatory	NULL
element	NULL
is	NULL
designated	NULL
PRRIL	NULL
(	NULL
B	NULL
)	NULL
Sequences	NULL
of	NULL
the	NULL
human	NULL
-137	NULL
to	NULL
-64	NULL
region	NULL
,	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
mutants	NULL
(	NULL
M1	NULL
to	NULL
M7	NULL
)	NULL
,	NULL
and	NULL
the	NULL
corresponding	NULL
region	NULL
from	NULL
the	NULL
murine	NULL
IL-2R	NULL
«	NULL
gene	NULL
.	NULL

Locations	NULL
of	NULL
mutations	NULL
:	NULL
M1	NULL
,	NULL
Elf-1	NULL
site	NULL
;	NULL
M2	NULL
,	NULL
all	NULL
three	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
sites	NULL
;	NULL
M3	NULL
,	NULL
Elf-1	NULL
and	NULL
all	NULL
three	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
sites	NULL
;	NULL
M4	NULL
,	NULL
major	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
site	NULL
;	NULL
M5	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
site	NULL
between	NULL
-128	NULL
and	NULL
-123	NULL
;	NULL
M6	NULL
,	NULL
putative	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
site	NULL
between	NULL
-90	NULL
to	NULL
-85	NULL
.	NULL

M7	NULL
,	NULL
double	NULL
mutant	NULL
containing	NULL
the	NULL
MS	NULL
and	NULL
M6	NULL
mutations	NULL
.	NULL

-	NULL
,	NULL
nucleotide	NULL
identical	NULL
to	NULL
that	NULL
in	NULL
the	NULL
human	NULL
sequence	NULL
;	NULL
A	NULL
,	NULL
deletion	NULL
.	NULL

Nuclear	NULL
extracts	NULL
,	NULL
antibodies	NULL
,	NULL
and	NULL
purified	NULL
protein	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
(	NULL
10	NULL
)	NULL
and	NULL
protein	NULL
concentrations	NULL
were	NULL
determined	NULL
with	NULL
a	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
kit	NULL
.	NULL

R4641	NULL
anti-human	NULL
Ets-1	NULL
(	NULL
45	NULL
)	NULL
,	NULL
anti-Ets-2	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
anti-HMG-I	NULL
(	NULL
Y	NULL
)	NULL
antibodies	NULL
1	NULL
and	NULL
2	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
11	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
anti-human	NULL
Elf-1	NULL
antiserum	NULL
was	NULL
produced	NULL
by	NULL
immunizing	NULL
rabbits	NULL
with	NULL
a	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-Elf-1	NULL
fusion	NULL
protein	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
(	NULL
20	NULL
pl	NULL
)	NULL
contained	NULL
2	NULL
pl	NULL
of	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
,	NULL
10,000	NULL
epm	NULL
of	NULL
probe	NULL
(	NULL
0.1	NULL
to	NULL
0.2	NULL
ng	NULL
)	NULL
,	NULL
2	NULL
mg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
HCI	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-N	NULL
'	NULL
-2-ethanesulfonic	NULL
acid	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1.25	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
15	NULL
%	NULL
glycerol	NULL
.	NULL

ing	NULL
IL-2Ra	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
different	NULL
physiological	NULL
stimuli	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
.	NULL

Jurkat	NULL
E6.1	NULL
,	NULL
MT-2	NULL
,	NULL
and	NULL
Kit	NULL
225	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
,	NULL
and	NULL
GM637	NULL
and	NULL
COS-7	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
,	NULL
each	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
U	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
glutamine	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
buffy	NULL
coats	NULL
or	NULL
leuka-	NULL
phereses	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
with	NULL
nylon	NULL
wool	NULL
(	NULL
26	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
RPMI-10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
for	NULL
48	NULL
h	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
PMA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
ionomycin	NULL
(	NULL
4	NULL
pg/ml	NULL
)	NULL
.	NULL

A	NULL
B	NULL
Following	NULL
incubation	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
,	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
analyzed	NULL
on	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
acrylamide/bisacrylamide	NULL
ratio	NULL
,	NULL
40:1	NULL
)	NULL
run	NULL
in	NULL
Tris-borate	NULL
buffer	NULL
at	NULL
150	NULL
V	NULL
for	NULL
2.5	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
2	NULL
pl	NULL
of	NULL
specific	NULL
antiserum	NULL
was	NULL
incubated	NULL
with	NULL
protein	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
prior	NULL
to	NULL
the	NULL
C	NULL
,	NULL
-2	NULL
44	NULL
44	NULL
Es	NULL
[	NULL
J	NULL
UNINDUCED	NULL
9064	NULL
-90/-64	NULL
EI	NULL
PMA	NULL
INDUCED	NULL
2	NULL
f	NULL
N	NULL
PMA	NULL
INDUCED	NULL
~103/74	NULL
103/74	NULL
[	NULL
]	NULL
UNINDUCED	NULL
2	NULL
13798	NULL
E	NULL
4	NULL
2	NULL
3	NULL
w	NULL
3	NULL
185/135	NULL
w	NULL
~185/150	NULL
~185/150	NULL
E	NULL
2	NULL
210/184	NULL
210/184	NULL
]	NULL
2761-244	NULL
2761-244	NULL
a	NULL
'	NULL
BLCAT2	NULL
0	NULL
p	NULL
I	NULL
T	NULL
T	NULL
I	NULL
T	NULL
T	NULL
T	NULL
vs	NULL
‘	NULL
b	NULL
\	NULL
&	NULL
“	NULL
é	NULL
“	NULL
Y	NULL
?	NULL

¢W	NULL
\	NULL
#	NULL
0	NULL
2	NULL
4	NULL
6	NULL
s	NULL
_	NULL
10	NULL
12	NULL
C	NULL
S	NULL
8	NULL
S	NULL
o	NULL
$	NULL
RELATIVE	NULL
CAT	NULL
ACTIVITY	NULL
4	NULL
JoC	NULL
Vo	NULL
4	NULL
&	NULL
B	NULL
D	NULL
<	NULL
L	NULL
IL	NULL
IL	NULL
I	NULL
GMes7	NULL
Cos	NULL
7	NULL
JURKAT	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
of	NULL
the	NULL
-276	NULL
to	NULL
-64	NULL
region	NULL
and	NULL
fragments	NULL
used	NULL
to	NULL
analyze	NULL
the	NULL
region	NULL
between	NULL
-210	NULL
and	NULL
-64	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Summary	NULL
of	NULL
CAT	NULL
assays	NULL
in	NULL
Jurkat	NULL
cells	NULL
performed	NULL
with	NULL
the	NULL
constructs	NULL
shown	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
pBLCAT2	NULL
without	NULL
PMA	NULL
treatment	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1	NULL
,	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
other	NULL
constructs	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
increase	NULL
over	NULL
this	NULL
activity	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Summary	NULL
of	NULL
CAT	NULL
assays	NULL
using	NULL
the	NULL
control	NULL
vector	NULL
pBLCAT2	NULL
and	NULL
pTKa-137/-64	NULL
in	NULL
GM637	NULL
,	NULL
COS-7	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
(	NULL
means	NULL
and	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
for	NULL
two	NULL
independent	NULL
experiments	NULL
for	NULL
GM637	NULL
and	NULL
COS-7	NULL
cells	NULL
and	NULL
three	NULL
assays	NULL
for	NULL
Jurkat	NULL
cells	NULL
)	NULL
.	NULL

Successful	NULL
transfection	NULL
in	NULL
GM637	NULL
and	NULL
COS-7	NULL
cells	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
pTK	NULL
«	NULL
B3	NULL
(	NULL
45	NULL
)	NULL
and	NULL
pSV2CAT	NULL
constructs	NULL
exhibited	NULL
significant	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

1788	NULL
JOHN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

B	NULL
Ix	NULL
-	NULL
©	NULL
TIME	NULL
AFTER	NULL
___LSS___	NULL
JSR	NULL
comPEtiTor	NULL
8	NULL
$	NULL
656	NULL
)	NULL
STIMULATION	NULL
0	NULL
1	NULL
4	NULL
9	NULL
24	NULL
0	NULL
1	NULL
4	NULL
9	NULL
24	NULL
0	NULL
8	NULL
l_	NULL
‘	NULL
—I+	NULL
°+°+g~|	NULL
|	NULL
popropropoproprommmmmapen	NULL
|	NULL
C	NULL
.	NULL

(	NULL
HRS	NULL
)	NULL
1	NULL
2	NULL
8	NULL
4	NULL
506	NULL
7	NULL
s	NULL
9	NULL
10	NULL
11	NULL
12	NULL
P008	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
4-A~m	NULL
A	NULL
-	NULL
»	NULL
R	NULL
idd	NULL
*~	NULL
%	NULL
``	NULL
M	NULL
:	NULL
a_	NULL
ug	NULL
2222	NULL
L__J	NULL
©	NULL
3	NULL
©	NULL
yi	NULL
NON-SPECIFIC	NULL
aS	NULL
(	NULL
32°	NULL
042°	NULL
MPETITOR	NULL
3	NULL
p	NULL
gr	NULL
<	NULL
4	NULL
é§°°oé	NULL
egeoe	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Inducible	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
*°P-labeled	NULL
-137/-64	NULL
probe	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Binding	NULL
reaction	NULL
mixtures	NULL
contained	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
or	NULL
1	NULL
pg	NULL
of	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
12	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
from	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
10	NULL
)	NULL
or	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
induced	NULL
with	NULL
20	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
the	NULL
indicated	NULL
periods	NULL
.	NULL

A	NULL
more	NULL
detailed	NULL
time	NULL
course	NULL
confirmed	NULL
the	NULL
lack	NULL
of	NULL
inducibility	NULL
of	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Specific	NULL
binding	NULL
of	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
.	NULL

Induced	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
0-	NULL
,	NULL
50-	NULL
,	NULL
or	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
-137/-64	NULL
oligonucleotide	NULL
or	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
either	NULL
the	NULL
AP1	NULL
digonucleotide	NULL
or	NULL
the	NULL
CREB	NULL
oligonucleotide	NULL
and	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

addition	NULL
of	NULL
probe	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
15-min	NULL
incubation	NULL
,	NULL
samples	NULL
were	NULL
analyzed	NULL
on	NULL
gels	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
excess	NULL
unlabeled	NULL
oligonucleotides	NULL
were	NULL
incubated	NULL
with	NULL
protein	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
;	NULL
a	NULL
``	NULL
P-labeled	NULL
DNA	NULL
probe	NULL
was	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
continued	NULL
for	NULL
a	NULL
further	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Oligonucleotides	NULL
,	NULL
plasmids	NULL
,	NULL
and	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
PRRI	NULL
,	NULL
PRRII	NULL
,	NULL
and	NULL
M1	NULL
to	NULL
M7	NULL
and	NULL
all	NULL
the	NULL
subfragments	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
were	NULL
synthesized	NULL
(	NULL
DNA/RNA	NULL
model	NULL
392	NULL
synthesizer	NULL
;	NULL
Applied	NULL
Biosys-tems	NULL
Inc.	NULL
)	NULL
with	NULL
HindIII	NULL
(	NULL
5	NULL
'	NULL
)	NULL
and	NULL
BemHI	NULL
(	NULL
3	NULL
'	NULL
)	NULL
ends	NULL
and	NULL
then	NULL
cloned	NULL
between	NULL
these	NULL
sites	NULL
in	NULL
pBLCAT2	NULL
(	NULL
47	NULL
)	NULL
.	NULL

IL-2Ra	NULL
«	NULL
mutant	NULL
M1	NULL
was	NULL
generated	NULL
by	NULL
PCR	NULL
mutagenesis	NULL
(	NULL
51	NULL
)	NULL
of	NULL
the	NULL
-472	NULL
to	NULL
+109	NULL
wild-type	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
construct	NULL
(	NULL
60	NULL
)	NULL
using	NULL
an	NULL
oligonucleotide	NULL
,	NULL
5'-AAAAAAAAAACACTTICTATATITGAGATGAG-3	NULL
'	NULL
,	NULL
which	NULL
changes	NULL
the	NULL
C	NULL
at	NULL
position	NULL
-92	NULL
to	NULL
a	NULL
T	NULL
(	NULL
underlined	NULL
)	NULL
.	NULL

IL-2R	NULL
«	NULL
M4	NULL
(	NULL
deletion	NULL
of	NULL
the	NULL
-116	NULL
to	NULL
-96	NULL
region	NULL
)	NULL
was	NULL
generated	NULL
with	NULL
the	NULL
Bio-Rad	NULL
Muta-Gene	NULL
kit	NULL
and	NULL
the	NULL
oligonucleotide	NULL
Both	NULL
mutants	NULL
were	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

The	NULL
double-stranded	NULL
oligonucleotide	NULL
competitors	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
were	NULL
as	NULL
follows	NULL
(	NULL
the	NULL
GGAA	NULL
,	NULL
CRE	NULL
,	NULL
and	NULL
AP-1	NULL
motifs	NULL
are	NULL
underlined	NULL
;	NULL
mutated	NULL
bases	NULL
are	NULL
boldfaced	NULL
)	NULL
:	NULL
MSV	NULL
LTR	NULL
,	NULL
5'-AGCTTCTCGGAGAGCGG	NULL
AAGCGCGCG-3	NULL
'	NULL
(	NULL
24	NULL
)	NULL
;	NULL
E74	NULL
,	NULL
5-AGCTTCTCTAGCTGAATAACCGGAAG	NULL
TAACTCATCG-3	NULL
'	NULL
(	NULL
77	NULL
)	NULL
;	NULL
NFAT	NULL
,	NULL
5'-AGCTTAGAAAGGAGGAAAAACTGTT	NULL
TCATACAGG-3	NULL
'	NULL
(	NULL
72	NULL
)	NULL
;	NULL
mNFAT	NULL
,	NULL
5'-AGCTTAGAAACGTCCTAAAACTGTT	NULL
TCATACAGG-3	NULL
'	NULL
(	NULL
72	NULL
)	NULL
,	NULL
CREB	NULL
,	NULL
AGAGAGC-3	NULL
'	NULL
(	NULL
50	NULL
)	NULL
;	NULL
PEA3	NULL
,	NULL
5'-AGCTTCGAGCAGGAAGTTCGG-3	NULL
'	NULL
(	NULL
80	NULL
)	NULL
;	NULL
mPEA3	NULL
,	NULL
5	NULL
``	NULL
-AGCTTCGAGCAAGAAGTTCGG-3	NULL
'	NULL
(	NULL
80	NULL
)	NULL
;	NULL
AP1	NULL
,	NULL
GAGTCAGCCGGAA-3	NULL
'	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
Elf-1	NULL
expression	NULL
vector	NULL
peDEIf-1	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
72	NULL
)	NULL
.	NULL

All	NULL
of	NULL
the	NULL
Elf-1	NULL
deletion	NULL
mutants	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
and	NULL
cloned	NULL
between	NULL
the	NULL
BamHI	NULL
and	NULL
Xbel	NULL
sites	NULL
of	NULL
peDNA3	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
construct	NULL
corresponded	NULL
to	NULL
the	NULL
1,680-bp	NULL
HindII-Xbel	NULL
fragment	NULL
(	NULL
encoding	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
502	NULL
)	NULL
of	NULL
the	NULL
KBF1	NULL
cDNA	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
c-Rel	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
and	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
SRF	NULL
)	NULL
cDNAs	NULL
have	NULL
been	NULL
reported	NULL
previously	NULL
(	NULL
4	NULL
,	NULL
57	NULL
,	NULL
61	NULL
)	NULL
.	NULL

The	NULL
HMG-I	NULL
expression	NULL
plasmid	NULL
pRe/CMVHMG-I	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
an	NULL
Xbal-HindIII	NULL
fragment	NULL
from	NULL
pBSHMG-I	NULL
(	NULL
30	NULL
)	NULL
between	NULL
these	NULL
sites	NULL
in	NULL
pRe/CMV	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

Transfection	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
DEAE-dextran	NULL
(	NULL
65	NULL
)	NULL
.	NULL

Transfections	NULL
of	NULL
IL-2Ra	NULL
«	NULL
enhancer	NULL
or	NULL
promoter	NULL
constructs	NULL
were	NULL
performed	NULL
with	NULL
5	NULL
or	NULL
10	NULL
pg	NULL
of	NULL
DNA	NULL
,	NULL
respectively	NULL
.	NULL

Cotransfection	NULL
experiments	NULL
with	NULL
COS-7	NULL
cells	NULL
were	NULL
performed	NULL
with	NULL
Lipofectamine	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
by	NULL
using	NULL
5	NULL
mg	NULL
of	NULL
reporter	NULL
and	NULL
3	NULL
ug	NULL
of	NULL
each	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
total	NULL
DNA	NULL
in	NULL
the	NULL
cotransfection	NULL
experiments	NULL
was	NULL
kept	NULL
constant	NULL
with	NULL
pUC13	NULL
DNA	NULL
.	NULL

Following	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
medium	NULL
for	NULL
24	NULL
to	NULL
30	NULL
h	NULL
and	NULL
then	NULL
were	NULL
treated	NULL
with	NULL
0	NULL
or	NULL
20	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
12	NULL
to	NULL
14	NULL
h.	NULL
Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
in	NULL
0.25	NULL
M	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
7.5	NULL
.	NULL

Extracts	NULL
were	NULL
clarified	NULL
at	NULL
65°C	NULL
for	NULL
10	NULL
min	NULL
and	NULL
assayed	NULL
for	NULL
protein	NULL
concentrations	NULL
with	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
kit	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
used	NULL
in	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
.	NULL

Acetylated	NULL
forms	NULL
of	NULL
chloramphenicol	NULL
were	NULL
separated	NULL
by	NULL
thin-layer	NULL
chromatography	NULL
and	NULL
quanti-tated	NULL
with	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
PhosphorImager	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
reaction	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
and	NULL
translation	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
Eukaryotic	NULL
in	NULL
vitro	NULL
translation	NULL
kit	NULL
or	NULL
the	NULL
TNT	NULL
transcription/translation	NULL
kit	NULL
(	NULL
both	NULL
from	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

For	NULL
the	NULL
former	NULL
,	NULL
pCDneo-Elf-1	NULL
(	NULL
72	NULL
)	NULL
pBSHMG-I	NULL
and	NULL
pBSHMG-Y	NULL
(	NULL
17	NULL
,	NULL
30	NULL
)	NULL
plasmids	NULL
were	NULL
linearized	NULL
at	NULL
Xhol	NULL
,	NULL
Xbal	NULL
,	NULL
and	NULL
BamHI	NULL
sites	NULL
,	NULL
respectively	NULL
.	NULL

For	NULL
the	NULL
latter	NULL
,	NULL
plasmids	NULL
were	NULL
not	NULL
linearized	NULL
.	NULL

Methylation	NULL
and	NULL
ethylation	NULL
interference	NULL
assays	NULL
.	NULL

pTKo-137/-64	NULL
was	NULL
lincar-ized	NULL
at	NULL
either	NULL
end	NULL
with	NULL
HindIII	NULL
or	NULL
BamHI	NULL
and	NULL
labeled	NULL
with	NULL
Klenow	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
,	NULL
by	NULL
using	NULL
[	NULL
«	NULL
-*°P	NULL
]	NULL
dATP	NULL
and	NULL
[	NULL
«	NULL
-P	NULL
]	NULL
4GTP	NULL
(	NULL
both	NULL
at	NULL
3,000	NULL
Ci/	NULL
mmol	NULL
and	NULL
both	NULL
from	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
labeled	NULL
insert	NULL
was	NULL
released	NULL
by	NULL
digesting	NULL
with	NULL
BamHI	NULL
or	NULL
HindIII	NULL
as	NULL
appropriate	NULL
and	NULL
gel	NULL
purified	NULL
.	NULL

Typically	NULL
,	NULL
0.5	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
end-labeled	NULL
probe	NULL
and	NULL
25	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
in	NULL
binding	NULL
reac-tions	NULL
.	NULL

Methylation	NULL
and	NULL
ethylation	NULL
interference	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
1	NULL
,	NULL
66	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
assay	NULL
.	NULL

Isolated	NULL
-137	NULL
to	NULL
-64	NULL
fragments	NULL
,	NULL
radiolabeled	NULL
at	NULL
either	NULL
the	NULL
bottom	NULL
strand	NULL
5	NULL
'	NULL
HindIII	NULL
site	NULL
or	NULL
the	NULL
top	NULL
strand	NULL
3	NULL
'	NULL
BemHI	NULL
site	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
recombinant	NULL
HMG-I	NULL
at	NULL
various	NULL
molar	NULL
ratios	NULL
of	NULL
protein	NULL
to	NULL
DNA	NULL
and	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
59	NULL
)	NULL
.	NULL

The	NULL
optimal	NULL
enzyme	NULL
concentration	NULL
and	NULL
digestion	NULL
time	NULL
for	NULL
cach	NULL
preparation	NULL
were	NULL
determined	NULL
empir-ically	NULL
.	NULL

DNA	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
9	NULL
%	NULL
sequencing	NULL
gel	NULL
(	NULL
acrylamide/bisacrylamide	NULL
ratio	NULL
,	NULL
37.5:1	NULL
)	NULL
with	NULL
a	NULL
buffer	NULL
containing	NULL
90	NULL
mM	NULL
Tris	NULL
,	NULL
90	NULL
mM	NULL
borate	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
EDTA	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
(	NULL
1x	NULL
TBE	NULL
)	NULL
.	NULL

GST	NULL
retention	NULL
and	NULL
c-Rel	NULL
and	NULL
HMG-I	NULL
association	NULL
assays	NULL
.	NULL

The	NULL
GST-Elf-1-Tag	NULL
plasmid	NULL
was	NULL
constructed	NULL
by	NULL
inserting	NULL
the	NULL
myc-tag	NULL
epitope	NULL
(	NULL
15	NULL
)	NULL
between	NULL
amino	NULL
acids	NULL
5	NULL
and	NULL
6	NULL
of	NULL
the	NULL
Elf-1	NULL
sequence	NULL
by	NULL
PCR	NULL
mutagenesis	NULL
(	NULL
51	NULL
)	NULL
,	NULL
and	NULL
this	NULL
Elf-myc-tag	NULL
cDNA	NULL
was	NULL
cloned	NULL
between	NULL
the	NULL
SmelI	NULL
and	NULL
Xhol	NULL
sites	NULL
of	NULL
pGEX	NULL
2Tplink	NULL
(	NULL
created	NULL
by	NULL
inserting	NULL
the	NULL
polylinker	NULL
5'-GATCCCGGGGCGGCCGCTCGA	NULL
GG-3	NULL
'	NULL
between	NULL
the	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
pGEX	NULL
2T	NULL
[	NULL
Pharmacia-LKB	NULL
]	NULL
)	NULL
.	NULL

The	NULL
recombinant	NULL
plasmids	NULL
were	NULL
verified	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

GST-Elf-Tag	NULL
protein	NULL
was	NULL
made	NULL
per	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Pharmacia-LKB	NULL
)	NULL
.	NULL

GST	NULL
fusion	NULL
proteins	NULL
on	NULL
beads	NULL
(	NULL
15	NULL
pl	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
3	NULL
ul	NULL
of	NULL
S-labeled	NULL
in	NULL
vitro-translated	NULL
protein	NULL
in	NULL
300	NULL
pl	NULL
of	NULL
NETN	NULL
binding	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
containing	NULL
0.1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
and	NULL
0	NULL
or	NULL
400	NULL
pg	NULL
of	NULL
ethidium	NULL
bromide	NULL
per	NULL
ml	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
in	NULL
binding	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
resolved	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

For	NULL
Fig	NULL
.	NULL

10A	NULL
,	NULL
10	NULL
``	NULL
MT-2	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
50	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
-120	NULL
mM	NULL
NaCl-0.5	NULL
%	NULL
Nonidet	NULL
P-40-protease	NULL
inhibitors	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

Cellular	NULL
lysates	NULL
were	NULL
clarified	NULL
by	NULL
centrifugation	NULL
at	NULL
17,680	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
400	NULL
pul	NULL
of	NULL
lysate	NULL
was	NULL
incubated	NULL
with	NULL
30	NULL
pl	NULL
of	NULL
GST-Elf-1	NULL
Sepharose	NULL
beads	NULL
in	NULL
300	NULL
l	NULL
of	NULL
NETN	NULL
buffer	NULL
.	NULL

The	NULL
GST	NULL
retention	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
,	NULL
and	NULL
the	NULL
specifically	NULL
bound	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
an	NULL
8	NULL
or	NULL
10	NULL
%	NULL
Tris-glycine	NULL
minigel	NULL
(	NULL
Novex	NULL
)	NULL
and	NULL
Western	NULL
blotted	NULL
(	NULL
immunoblotted	NULL
)	NULL
with	NULL
anti-NF-	NULL
«	NULL
B	NULL
p50	NULL
or	NULL
c-Rel	NULL
antiserum	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Fifty	NULL
microliters	NULL
of	NULL
c-Rel	NULL
(	NULL
1-300	NULL
)	NULL
coupled	NULL
to	NULL
agarose	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
or	NULL
HMG-I	NULL
coupled	NULL
to	NULL
agarose	NULL
via	NULL
its	NULL
C	NULL
terminus	NULL
was	NULL
incubated	NULL
with	NULL
3	NULL
to	NULL
5	NULL
pl	NULL
of	NULL
S-labeled	NULL
in	NULL
vitro-translated	NULL
Elf-1	NULL
proteins	NULL
in	NULL
300	NULL
pl	NULL
of	NULL
NETN	NULL
containing	NULL
1	NULL
mg	NULL
of	NULL
BSA	NULL
per	NULL
ml	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
beads	NULL
were	NULL
then	NULL
processed	NULL
as	NULL
described	NULL
above	NULL
for	NULL
the	NULL
GST	NULL
retention	NULL
assay	NULL
,	NULL
and	NULL
coprecipitated	NULL
proteins	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

All	NULL
other	NULL
reactions	NULL
were	NULL
resolved	NULL
on	NULL
8	NULL
to	NULL
16	NULL
%	NULL
Tris-glycine	NULL
minigels	NULL
.	NULL

The	NULL
Elf	NULL
(	NULL
207-303	NULL
)	NULL
reaction	NULL
for	NULL
the	NULL
c-Rel	NULL
coprecipitation	NULL
assay	NULL
was	NULL
resolved	NULL
on	NULL
an	NULL
18	NULL
%	NULL
Tris-glycine	NULL
minigel	NULL
.	NULL

Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
RESULTS	NULL
Identification	NULL
of	NULL
a	NULL
new	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
existence	NULL
of	NULL
important	NULL
elements	NULL
downstream	NULL
of	NULL
PRRI	NULL
,	NULL
we	NULL
cloned	NULL
a	NULL
series	NULL
of	NULL
IL-2Ra	NULL
fragments	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
in	NULL
pBLCAT2	NULL
(	NULL
47	NULL
)	NULL
and	NULL
assayed	NULL
their	NULL
abilities	NULL
to	NULL
promote	NULL
transcription	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
revealed	NULL
that	NULL
the	NULL
-137	NULL
to	NULL
-64	NULL
construct	NULL
(	NULL
pTKa-137/-64	NULL
)	NULL
exhibited	NULL
significantly	NULL
higher	NULL
levels	NULL
of	NULL
transcription	NULL
in	NULL
unstimulated	NULL
and	NULL
PMA-stimulated	NULL
Jurkat	NULL
cells	NULL
than	NULL
did	NULL
the	NULL
control	NULL
plasmid	NULL
,	NULL
pBLCAT2	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Truncation	NULL
of	NULL
the	NULL
-137	NULL
to	NULL
-64	NULL
region	NULL
diminished	NULL
transcriptional	NULL
activity	NULL
,	NULL
and	NULL
therefore	NULL
we	NULL
assigned	NULL
-137	NULL
and	NULL
-64	NULL
as	NULL
the	NULL
boundaries	NULL
of	NULL
this	NULL
novel	NULL
IL-2Ra	NULL
«	NULL
positive	NULL
regulatory	NULL
region	NULL
(	NULL
PRRII	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
,	NULL
the	NULL
sequence	NULL
of	NULL
which	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

Since	NULL
IL-2Ra	NULL
expression	NULL
is	NULL
restricted	NULL
principally	NULL
to	NULL
lymphoid	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
noteworthy	NULL
that	NULL
pTKa-137/-64	NULL
was	NULL
not	NULL
transcriptionally	NULL
active	NULL
in	NULL
two	NULL
nonlymphoid	NULL
cell	NULL
lines	NULL
,	NULL
GM637	NULL
and	NULL
COS-7	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
;	NULL
thus	NULL
,	NULL
its	NULL
expression	NULL
appeared	NULL
to	NULL
exhibit	NULL
cell	NULL
type	NULL
specific-ity	NULL
.	NULL

Identification	NULL
of	NULL
nuclear	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
PRRII	NULL
.	NULL

Factors	NULL
binding	NULL
to	NULL
PRRII	NULL
were	NULL
identified	NULL
by	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
and	NULL
PMA-stimulated	NULL
normal	NULL
and	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

When	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
nonspecific	NULL
competitor	NULL
,	NULL
only	NULL
complex	NULL
A	NULL
was	NULL
observed	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
,	NULL
whereas	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
12	NULL
)	NULL
or	NULL
poly	NULL
(	NULL
dG-dC	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
faster-mobility	NULL
complex	NULL
B	NULL
was	NULL
also	NULL
detected	NULL
.	NULL

Complex	NULL
A	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
it	NULL
was	NULL
only	NULL
weakly	NULL
detected	NULL
in	NULL
resting	NULL
normal	NULL
T	NULL
cells	NULL
but	NULL
increased	NULL
following	NULL
mitogenic	NULL
stimulation	NULL
and	NULL
then	NULL
declined	NULL
by	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Complex	NULL
B	NULL
was	NULL
also	NULL
constitutively	NULL
present	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

In	NULL
normal	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
modestly	NULL
induced	NULL
and	NULL
continued	NULL
to	NULL
increase	NULL
for	NULL
at	NULL
least	NULL
24	NULL
h	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
.	NULL

Both	NULL
complexes	NULL
were	NULL
specific	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
unlabeled	NULL
-137/-64	NULL
,	NULL
but	NULL
not	NULL
API	NULL
or	NULL
CREB	NULL
,	NULL
oligonucleotides	NULL
to	NULL
inhibit	NULL
their	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
versus	NULL
3	NULL
)	NULL
.	NULL

The	NULL
additional	NULL
band	NULL
at	NULL
the	NULL
9-h	NULL
time	NULL
point	NULL
in	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
was	NULL
variably	NULL
detected	NULL
,	NULL
and	NULL
its	NULL
identity	NULL
is	NULL
unknown	NULL
.	NULL

Complexes	NULL
A	NULL
and	NULL
B	NULL
were	NULL
also	NULL
induced	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
and	NULL
analogously	NULL
to	NULL
the	NULL
situation	NULL
for	NULL
Jurkat	NULL
,	NULL
they	NULL
were	NULL
constitutively	NULL
expressed	NULL
in	NULL
three	NULL
other	NULL
lymphoid	NULL
cell	NULL
lines	NULL
tested	NULL
(	NULL
MT-2	NULL
and	NULL
Kit-225	NULL
T	NULL
cells	NULL
and	NULL
YT-1	NULL
natural	NULL
killer-like	NULL
cells	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Complex	NULL
A	NULL
contains	NULL
Elf-1	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
nucleotides	NULL
contacted	NULL
in	NULL
complex	NULL
A	NULL
,	NULL
we	NULL
performed	NULL
methylation	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
and	NULL
ethylation	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
interference	NULL
assays	NULL
.	NULL

Methylation	NULL
of	NULL
the	NULL
bottom	NULL
strand	NULL
G	NULL
residues	NULL
at	NULL
positions	NULL
-91	NULL
and	NULL
-92	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
strongly	NULL
diminished	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
ethylation	NULL
interference	NULL
assays	NULL
confirmed	NULL
these	NULL
results	NULL
and	NULL
additionally	NULL
showed	NULL
strong	NULL
protection	NULL
of	NULL
nucleotides	NULL
-88	NULL
,	NULL
-90	NULL
,	NULL
-93	NULL
,	NULL
-94	NULL
,	NULL
-95	NULL
and	NULL
weaker	NULL
protection	NULL
of	NULL
nucleotides	NULL
-85	NULL
and	NULL
-86	NULL
on	NULL
the	NULL
bottom	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
-87	NULL
and	NULL
-89	NULL
on	NULL
the	NULL
top	NULL
strand	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
protected	NULL
nucleotides	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
span	NULL
a	NULL
GGAA	NULL
purine-rich	NULL
motif	NULL
(	NULL
-91	NULL
to	NULL
-94	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
complex	NULL
A	NULL
contained	NULL
an	NULL
Ets	NULL
family	NULL
protein	NULL
.	NULL

Members	NULL
of	NULL
this	NULL
family	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
a	NULL
number	NULL
of	NULL
lymphoid-tissue-specific	NULL
genes	NULL
(	NULL
22	NULL
,	NULL
28	NULL
,	NULL
78	NULL
;	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
references	NULL
6	NULL
,	NULL
49	NULL
,	NULL
and	NULL
63	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
identify	NULL
the	NULL
Ets	NULL
family	NULL
protein	NULL
contained	NULL
in	NULL
complex	NULL
A	NULL
,	NULL
we	NULL
performed	NULL
antibody	NULL
supershift	NULL
and	NULL
oligonucleotide	NULL
competition	NULL
analyses	NULL
.	NULL

Antibodies	NULL
to	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
did	NULL
not	NULL
block	NULL
or	NULL
supershift	NULL
complex	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

IL-2R	NULL
«	NULL
EXPRESSION	NULL
1789	NULL
A	NULL
B	NULL
PROTEIN	NULL
NUCLEAR	NULL
NUCLEAR	NULL
EXTRACT	NULL
EXTRACT	NULL
TOP	NULL
_	NULL
BOT	NULL
TOP	NULL
BOT	NULL
F	NULL
B	NULL
F	NULL
B	NULL
F	NULL
B	NULL
F	NULL
B	NULL
oe	NULL
so	NULL
og	NULL
P	NULL
wae	NULL
©	NULL
a	NULL
.	NULL

.	NULL

wo	NULL
use	NULL
wa	NULL
e	NULL
ms	NULL
ms	NULL
ed	NULL
!	NULL

|	NULL
#	NULL
=~	NULL
:	NULL
@	NULL
a	NULL
»	NULL
«	NULL
»	NULL
an	NULL
&	NULL
*	NULL
aw	NULL
we	NULL
!	NULL

ap	NULL
«	NULL
»	NULL
0	NULL
we	NULL
am	NULL
0	NULL
e	NULL
ane	NULL
wite	NULL
«	NULL
»	NULL
as	NULL
le	NULL
se	NULL
wan	NULL
wan	NULL
M	NULL
boned	NULL
[	NULL
d	NULL
'd	NULL
0	NULL
«	NULL
*	NULL
ae	NULL
ae	NULL
1	NULL
2	NULL
3	NULL
4	NULL
«	NULL
ae	NULL
cms	NULL
DEPC	NULL
o	NULL
a	NULL
o	NULL
o	NULL
U	NULL
DMs	NULL
130	NULL
120	NULL
-110	NULL
~190	NULL
~s0	NULL
~s0	NULL
e	NULL
AnkotamamrorcamcanaaaaaRAAAAAAAAAAACACTTCCTATATTTGAGATGAGAGAAGAGAGTCC	NULL
TTT	NULL
GT	NULL
AACTCTACTCTCTICTCTCACG	NULL
DMS	NULL
so	NULL
DEPC	NULL
eccese	NULL
o	NULL
co	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Methylation	NULL
and	NULL
ethylation	NULL
interference	NULL
analyses	NULL
of	NULL
complex	NULL
A.	NULL
Double-stranded	NULL
-137	NULL
to	NULL
-64	NULL
probes	NULL
labeled	NULL
on	NULL
the	NULL
top	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
bottom	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
strand	NULL
were	NULL
partially	NULL
methylated	NULL
(	NULL
A	NULL
)	NULL
with	NULL
dimethyl	NULL
]	NULL
sulfate	NULL
(	NULL
DMS	NULL
)	NULL
or	NULL
ethylated	NULL
with	NULL
diethylpyrocarbamate	NULL
(	NULL
DEPC	NULL
)	NULL
(	NULL
B	NULL
)	NULL
and	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
bound	NULL
.	NULL

Free	NULL
(	NULL
F	NULL
)	NULL
and	NULL
bound	NULL
(	NULL
B	NULL
)	NULL
probes	NULL
from	NULL
complex	NULL
A	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
,	NULL
treated	NULL
with	NULL
piperidine	NULL
,	NULL
lyophilized	NULL
,	NULL
resolved	NULL
on	NULL
9	NULL
%	NULL
denaturing	NULL
gels	NULL
,	NULL
and	NULL
autoradiographed	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
data	NULL
from	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
.	NULL

Strong	NULL
(	NULL
solid	NULL
circles	NULL
)	NULL
and	NULL
weak	NULL
(	NULL
squares	NULL
)	NULL
interferences	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
A	NULL
residue	NULL
at	NULL
position	NULL
-80	NULL
is	NULL
hyperethylated	NULL
by	NULL
DEPC	NULL
(	NULL
open	NULL
circle	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
polyomavirus	NULL
enhancer	NULL
(	NULL
PEA3	NULL
)	NULL
oligonucleotide	NULL
capable	NULL
of	NULL
binding	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
did	NULL
not	NULL
inhibit	NULL
complex	NULL
A	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

The	NULL
Moloney	NULL
murine	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
MSV	NULL
LTR	NULL
)	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
NFAT	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
oligonucleotides	NULL
competed	NULL
to	NULL
a	NULL
small	NULL
extent	NULL
,	NULL
while	NULL
the	NULL
Drosophila	NULL
E74	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
blocked	NULL
complex	NULL
A	NULL
formation	NULL
.	NULL

CREB	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
AP1	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
,	NULL
and	NULL
mutant	NULL
NFAT	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
oligonucleotides	NULL
did	NULL
not	NULL
compete	NULL
.	NULL

This	NULL
specificity	NULL
pattern	NULL
suggested	NULL
that	NULL
the	NULL
T-cell-specific	NULL
protein	NULL
Elf-1	NULL
,	NULL
which	NULL
is	NULL
closely	NULL
related	NULL
to	NULL
the	NULL
Drosophila	NULL
E74	NULL
protein	NULL
(	NULL
72	NULL
,	NULL
79	NULL
)	NULL
,	NULL
was	NULL
the	NULL
most	NULL
likely	NULL
Ets	NULL
family	NULL
protein	NULL
binding	NULL
to	NULL
PRRII	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
hypothesis	NULL
,	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
Elf-1	NULL
inhibited	NULL
complex	NULL
A	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lane	NULL
2	NULL
versus	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

1790	NULL
JOHN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
B	NULL
C	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

$	NULL
D	NULL
w	NULL
COMPETITOR	NULL
oLiGos	NULL
n/	NULL
<	NULL
a	NULL
5	NULL
ho	NULL
3	NULL
momo	NULL
(	NULL
h	NULL
yO	NULL
CC	NULL
Aun	NULL
an	NULL
a	NULL
NLC	NULL
5-4	NULL
E	NULL
i-	NULL
a	NULL
PROTEIN	NULL
&	NULL
_	NULL
~	NULL
45	NULL
§	NULL
8	NULL
an	NULL
GC	NULL
a	NULL
&	NULL
&	NULL
-	NULL
3.358	NULL
$	NULL
8	NULL
o	NULL
;	NULL
rnose	NULL
Ow	NULL
wT	NULL
_	NULL
omi	NULL
PROTEIN	NULL
.	NULL

¢	NULL
<	NULL
gy	NULL
[	NULL
(	NULL
E	NULL
%	NULL
80	NULL
_	NULL
.We	NULL
.	NULL

%	NULL
antisopny	NULL
TO	NULL
ANTIBODY	NULL
``	NULL
7	NULL
£	NULL
!	NULL

``	NULL
7	NULL
{	NULL
(	NULL
94	NULL
2	NULL
3	NULL
al	NULL
(	NULL
q	NULL
p	NULL
s	NULL
4a	NULL
s	NULL
67s	NULL
a'ho	NULL
11	NULL
1	NULL
200	NULL
8	NULL
4	NULL
506	NULL
7	NULL
t	NULL
w	NULL
wo	NULL
wat	NULL
tun	NULL
ins	NULL
<	NULL
a	NULL
HHH	NULL
m	NULL
a	NULL
#	NULL
@	NULL
|	NULL
&	NULL
be	NULL
o	NULL
<	NULL
-	NULL
Elf-1	NULL
``	NULL
``	NULL
T	NULL
``	NULL
``	NULL
Mme	NULL
g	NULL
M	NULL
m	NULL
i	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Elf-1	NULL
is	NULL
a	NULL
component	NULL
of	NULL
complex	NULL
A	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Binding	NULL
reaction	NULL
mixtures	NULL
containing	NULL
2	NULL
ag	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
plus	NULL
ionomycin	NULL
(	NULL
4	NULL
pg/ml	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
no	NULL
antibody	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
preimmune	NULL
serum	NULL
,	NULL
anti-Ets-1	NULL
(	NULL
a-Ets-1	NULL
)	NULL
antibody	NULL
R4641	NULL
,	NULL
or	NULL
anti-Ets-2	NULL
(	NULL
«	NULL
-Ets-2	NULL
)	NULL
antibody	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
*°P-labeled	NULL
-137/-64	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Competition	NULL
for	NULL
complex	NULL
A	NULL
binding	NULL
by	NULL
various	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
.	NULL

Prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
,	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
without	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
oligos	NULL
)	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
7	NULL
,	NULL
and	NULL
10	NULL
)	NULL
or	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
unlabeled	NULL
MSV	NULL
LTR	NULL
,	NULL
E74	NULL
,	NULL
wild-type	NULL
or	NULL
mutant	NULL
(	NULL
m	NULL
)	NULL
NFAT	NULL
oligonucleotide	NULL
,	NULL
CREB	NULL
,	NULL
wild-type	NULL
or	NULL
mutant	NULL
PEA3	NULL
oligonucleotide	NULL
,	NULL
or	NULL
an	NULL
AP-1	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
salmon	NULL
sperm	NULL
DNA	NULL
and	NULL
either	NULL
no	NULL
antibody	NULL
or	NULL
an	NULL
anti-Elf-1	NULL
antibody	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
-137	NULL
to	NULL
-64	NULL
probe	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
containing	NULL
unprogrammed	NULL
lysate	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
Elf-1	NULL
cRNA-programmed	NULL
lysate	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
7	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
no	NULL
antibody	NULL
,	NULL
preimmune	NULL
serum	NULL
(	NULL
P	NULL
)	NULL
,	NULL
or	NULL
anti-Elf-1	NULL
antibody	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
M1	NULL
mutant	NULL
or	NULL
wild-type	NULL
-137	NULL
to	NULL
-64	NULL
probe	NULL
.	NULL

The	NULL
upper	NULL
Elf-1	NULL
complex	NULL
(	NULL
arrow	NULL
)	NULL
comigrates	NULL
with	NULL
complex	NULL
A	NULL
from	NULL
nuclear	NULL
extracts	NULL
;	NULL
a	NULL
faster-migrating	NULL
Elf-1	NULL
specific	NULL
complex	NULL
is	NULL
often	NULL
seen	NULL
with	NULL
in	NULL
vitro-translated	NULL
Elf-1	NULL
(	NULL
dot	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
In	NULL
vitro-translated	NULL
Elf-1	NULL
protein	NULL
or	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
an	NULL
anti-Elf-1	NULL
monoclonal	NULL
antibody	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
wild-type	NULL
-137	NULL
to	NULL
-64	NULL
probe	NULL
.	NULL

Dashed	NULL
arrow	NULL
,	NULL
new	NULL
supershifted	NULL
Elf-1	NULL
complex	NULL
.	NULL

Additionally	NULL
,	NULL
EMSAs	NULL
using	NULL
Elf-1-programmed	NULL
rabbit	NULL
reticulo-cyte	NULL
lysates	NULL
yielded	NULL
a	NULL
major	NULL
complex	NULL
that	NULL
comigrated	NULL
with	NULL
complex	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

A	NULL
second	NULL
faster-mobility	NULL
complex	NULL
,	NULL
which	NULL
is	NULL
also	NULL
related	NULL
to	NULL
Elf-1	NULL
(	NULL
and	NULL
perhaps	NULL
represents	NULL
a	NULL
degradation	NULL
product	NULL
of	NULL
Elf-1	NULL
)	NULL
,	NULL
since	NULL
its	NULL
formation	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
antiserum	NULL
to	NULL
Elf-1	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
but	NULL
not	NULL
by	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
was	NULL
often	NULL
seen	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
Elf-1	NULL
can	NULL
supershift	NULL
the	NULL
Elf-1	NULL
complex	NULL
to	NULL
a	NULL
new	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

Methylation	NULL
and	NULL
ethylation	NULL
interference	NULL
assays	NULL
of	NULL
both	NULL
complexes	NULL
seen	NULL
with	NULL
in	NULL
vitro-translated	NULL
Elf-1	NULL
protein	NULL
yielded	NULL
results	NULL
identical	NULL
to	NULL
those	NULL
obtained	NULL
with	NULL
complex	NULL
A	NULL
from	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
GGAA	NULL
sequence	NULL
(	NULL
M1	NULL
)	NULL
abrogated	NULL
Elf-1	NULL
binding	NULL
activity	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
above	NULL
data	NULL
together	NULL
indicate	NULL
that	NULL
complex	NULL
A	NULL
contains	NULL
Elf-1	NULL
.	NULL

Complex	NULL
B	NULL
contains	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
.	NULL

The	NULL
IL-2Ra	NULL
promoter	NULL
con	NULL
B	NULL
¢	NULL
&	NULL
C	NULL
R	NULL
&	NULL
Cr	NULL
Ee	NULL
Cy	NULL
&	NULL
CC	NULL
Sf	NULL
Protem	NULL
_.	NULL
we	NULL
rhoten	NULL
-	NULL
#	NULL
s	NULL
PROTEIN	NULL
_	NULL
&	NULL
~	NULL
X	NULL
_C	NULL
ANTIBODY	NULL
+P	NULL
-	NULL
4	NULL
P	NULL
ANTIBODY	NULL
+	NULL
P	NULL
123	NULL
1	NULL
2	NULL
374	NULL
5	NULL
6	NULL
1	NULL
2	NULL
3	NULL
.	NULL

.	NULL

ts	NULL
tut	NULL
<	NULL
-	NULL
A	NULL
A-	NULL
»	NULL
U	NULL
.	NULL

e	NULL
*	NULL
w	NULL
}	NULL
<	NULL
-	NULL
B	NULL
Woo	NULL
~	NULL
«	NULL
W	NULL
=	NULL
-	NULL
t	NULL
as	NULL
UP	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binds	NULL
to	NULL
PRRII	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSAs	NULL
using	NULL
unprogrammed	NULL
(	NULL
-	NULL
)	NULL
or	NULL
HMG-I-	NULL
or	NULL
HMG-Y-programmed	NULL
lysates	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
or	NULL
purified	NULL
recombinant	NULL
human	NULL
HMG-I	NULL
(	NULL
rHMG-I	NULL
)	NULL
was	NULL
preincubated	NULL
with	NULL
no	NULL
antibody	NULL
,	NULL
anti-HMG-I	NULL
(	NULL
Y	NULL
)	NULL
antibody	NULL
1	NULL
,	NULL
or	NULL
preimmune	NULL
serum	NULL
(	NULL
P	NULL
)	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

Purified	NULL
rHMG-I	NULL
comigrated	NULL
with	NULL
complex	NULL
B	NULL
from	NULL
nuclear	NULL
extracts	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
either	NULL
poly	NULL
(	NULL
dG-dC	NULL
)	NULL
or	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
used	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSAs	NULL
were	NULL
performed	NULL
as	NULL
for	NULL
panel	NULL
B	NULL
with	NULL
salmon	NULL
sperm	NULL
DNA	NULL
as	NULL
the	NULL
nonspecific	NULL
competitor	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
with	NULL
no	NULL
antibody	NULL
,	NULL
anti-HMG-I	NULL
(	NULL
Y	NULL
)	NULL
antibody	NULL
2	NULL
,	NULL
or	NULL
preimmune	NULL
serum	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
supershifted	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
-DNA-antibody	NULL
ternary	NULL
complex	NULL
is	NULL
indicated	NULL
(	NULL
dot	NULL
)	NULL
.	NULL

tains	NULL
several	NULL
AT-rich	NULL
sequences	NULL
(	NULL
29	NULL
,	NULL
40	NULL
,	NULL
67	NULL
)	NULL
,	NULL
the	NULL
longest	NULL
of	NULL
which	NULL
is	NULL
19	NULL
bp	NULL
long	NULL
(	NULL
-116	NULL
to	NULL
=-98	NULL
)	NULL
and	NULL
is	NULL
contained	NULL
within	NULL
PRRII	NULL
.	NULL

Several	NULL
lines	NULL
of	NULL
evidence	NULL
indicated	NULL
that	NULL
complex	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
contained	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
proteins	NULL
,	NULL
low-molecular-weight	NULL
(	NULL
11,000	NULL
to	NULL
12,000	NULL
)	NULL
high-mobility	NULL
group	NULL
proteins	NULL
that	NULL
bind	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
of	NULL
AT-rich	NULL
sequences	NULL
.	NULL

First	NULL
,	NULL
complex	NULL
B	NULL
was	NULL
not	NULL
readily	NULL
detected	NULL
when	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
nonspecific	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
a	NULL
feature	NULL
exhibited	NULL
by	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
in	NULL
vitro-translated	NULL
HMG-I	NULL
and	NULL
HMG-Y	NULL
bound	NULL
to	NULL
PRRII	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
purified	NULL
recombinant	NULL
human	NULL
HMG-I	NULL
protein	NULL
yielded	NULL
a	NULL
complex	NULL
that	NULL
comigrated	NULL
with	NULL
complex	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
4	NULL
versus	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
an	NULL
antiserum	NULL
to	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
but	NULL
not	NULL
preimmune	NULL
serum	NULL
,	NULL
supershifted	NULL
complex	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lane	NULL
2	NULL
versus	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
two	NULL
supershifted	NULL
ternary	NULL
complexes	NULL
were	NULL
formed	NULL
,	NULL
with	NULL
purified	NULL
HMG-I	NULL
or	NULL
nuclear	NULL
extracts	NULL
,	NULL
with	NULL
the	NULL
lower	NULL
one	NULL
approximately	NULL
superimposed	NULL
on	NULL
complex	NULL
A	NULL
(	NULL
lane	NULL
2	NULL
versus	NULL
lane	NULL
3	NULL
and	NULL
lane	NULL
5	NULL
versus	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

A	NULL
second	NULL
polyclonal	NULL
antiserum	NULL
to	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
which	NULL
yields	NULL
only	NULL
one	NULL
supershifted	NULL
complex	NULL
with	NULL
purified	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
(	NULL
16	NULL
)	NULL
,	NULL
allowed	NULL
us	NULL
to	NULL
visualize	NULL
the	NULL
disappearance	NULL
of	NULL
complex	NULL
A	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
the	NULL
lymphotoxin	NULL
gene	NULL
(	NULL
16	NULL
)	NULL
,	NULL
this	NULL
antibody	NULL
supershifts	NULL
the	NULL
faster-mobility	NULL
complex	NULL
containing	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
and	NULL
blocks	NULL
the	NULL
formation	NULL
of	NULL
more	NULL
slowly	NULL
migrating	NULL
complexes	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
this	NULL
antiserum	NULL
on	NULL
complex	NULL
A	NULL
suggests	NULL
that	NULL
this	NULL
complex	NULL
contains	NULL
not	NULL
only	NULL
Elf-1	NULL
but	NULL
also	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
or	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
antigeni-cally	NULL
similar	NULL
to	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
lane	NULL
2	NULL
versus	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
can	NULL
exist	NULL
as	NULL
a	NULL
cocomplex	NULL
with	NULL
Elf-1	NULL
in	NULL
complex	NULL
A	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
control	NULL
preimmune	NULL
serum	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
EMSA	NULL
binding	NULL
pattern	NULL
seen	NULL
with	NULL
nuclear	NULL
extract	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
compare	NULL
lanes	NULL
3	NULL
and	NULL
1	NULL
)	NULL
.	NULL

To	NULL
define	NULL
the	NULL
DNA	NULL
sequences	NULL
in	NULL
PRRII	NULL
contacted	NULL
by	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
we	NULL
performed	NULL
DNase	NULL
I	NULL
footprinting	NULL
using	NULL
purified	NULL
HMG-I	NULL
protein	NULL
and	NULL
the	NULL
-137/-64	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
conditions	NULL
used	NULL
,	NULL
two	NULL
AT-rich	NULL
regions	NULL
between	NULL
-128	NULL
to	NULL
-123	NULL
(	NULL
region	NULL
A	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
and	NULL
the	NULL
poly	NULL
(	NULL
A	NULL
T	NULL
)	NULL
stretch	NULL
between	NULL
nucleotides	NULL
-116	NULL
and	NULL
-98	NULL
(	NULL
region	NULL
B	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
and	NULL
B	NULL
)	NULL
were	NULL
protected	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
these	NULL
sites	NULL
were	NULL
contacted	NULL
by	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
we	NULL
performed	NULL
EMSAs	NULL
with	NULL
wild-type	NULL
and	NULL
mu	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
A	NULL
Top	NULL
B	NULL
-134-	NULL
«	NULL
wi	NULL
``	NULL
D	NULL
2	NULL
,	NULL
122-	NULL
u	NULL
wae	NULL
wa	NULL
cae	NULL
cas-	NULL
lie	NULL
mate	NULL
wae	NULL
~117-ne	NULL
mes	NULL
«	NULL
ome	NULL
~~	NULL
@	NULL
-can	NULL
-129-	NULL
t	NULL
#	NULL
-133-135-	NULL
UM	NULL
136-proteim	NULL
_______IBMG	NULL
!	NULL

___	NULL
b	NULL
ProBEs	NULL
«	NULL
at	NULL
S66	NULL
¢	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
C1	NULL
-	NULL
»	NULL
2	NULL
~	NULL
.	NULL

uud	NULL
zigzag	NULL
“	NULL
|	NULL
-80	NULL
70	NULL
64	NULL
ELF-1	NULL
COMPLEX	NULL
~130	NULL
+120	NULL
HMG-I	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
analysis	NULL
of	NULL
recombinant	NULL
human	NULL
HMG-I	NULL
(	NULL
rHMG-I	NULL
)	NULL
bound	NULL
in	NULL
vitro	NULL
to	NULL
double-stranded	NULL
-137	NULL
to	NULL
-64	NULL
probes	NULL
labeled	NULL
on	NULL
the	NULL
top	NULL
(	NULL
A	NULL
)	NULL
or	NULL
bottom	NULL
(	NULL
B	NULL
)	NULL
strand	NULL
.	NULL

Reactions	NULL
were	NULL
performed	NULL
at	NULL
a	NULL
20:1	NULL
protein/DNA	NULL
molar	NULL
ratio	NULL
.	NULL

G	NULL
,	NULL
Maxam-Gilbert	NULL
G	NULL
lanes	NULL
;	NULL
-	NULL
,	NULL
free	NULL
DNA	NULL
;	NULL
+	NULL
,	NULL
DNA	NULL
plus	NULL
HMG-I	NULL
.	NULL

The	NULL
two	NULL
protected	NULL
regions	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
are	NULL
indicated	NULL
(	NULL
C	NULL
)	NULL
EMSAs	NULL
of	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
mutant	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
*°P-labeled	NULL
-137/-64	NULL
probes	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
in	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
contained	NULL
10	NULL
,	NULL
25	NULL
,	NULL
50	NULL
,	NULL
75	NULL
,	NULL
and	NULL
100	NULL
ng	NULL
of	NULL
rHMG-I	NULL
protein	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
cach	NULL
contained	NULL
75	NULL
ng	NULL
of	NULL
rHMG-I	NULL
protein	NULL
.	NULL

The	NULL
M4	NULL
probe	NULL
exhibited	NULL
faster	NULL
mobility	NULL
since	NULL
it	NULL
is	NULL
shorter	NULL
than	NULL
the	NULL
other	NULL
probes	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
identified	NULL
by	NULL
DNase	NULL
I	NULL
footprinting	NULL
(	NULL
solid	NULL
ellipses	NULL
;	NULL
-116	NULL
to	NULL
-98	NULL
and	NULL
-128	NULL
to	NULL
-123	NULL
)	NULL
and	NULL
a	NULL
third	NULL
possible	NULL
site	NULL
suggested	NULL
by	NULL
EMSAs	NULL
with	NULL
oligonucleotides	NULL
mutated	NULL
at	NULL
these	NULL
sites	NULL
(	NULL
stippled	NULL
ellipse	NULL
;	NULL
-90	NULL
to	NULL
-84	NULL
)	NULL
.	NULL

HMG-I	NULL
(	NULL
Y	NULL
)	NULL
bound	NULL
with	NULL
highest	NULL
affinity	NULL
to	NULL
the	NULL
-116	NULL
to	NULL
-98	NULL
region	NULL
.	NULL

IL-2R	NULL
«	NULL
EXPRESSION	NULL
1791	NULL
tant	NULL
-137/-64	NULL
oligonucleotides	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
mutant	NULL
oligonucleotides	NULL
used	NULL
in	NULL
this	NULL
study	NULL
are	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

Titrations	NULL
of	NULL
purified	NULL
HMG-I	NULL
suggested	NULL
that	NULL
two	NULL
complexes	NULL
of	NULL
different	NULL
affinities	NULL
could	NULL
form	NULL
with	NULL
the	NULL
-137/-64	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
.	NULL

Complex	NULL
C2	NULL
represented	NULL
a	NULL
protein-DNA	NULL
interaction	NULL
of	NULL
high	NULL
affinity	NULL
,	NULL
since	NULL
it	NULL
was	NULL
apparent	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
only	NULL
10	NULL
ng	NULL
of	NULL
purified	NULL
protein	NULL
,	NULL
while	NULL
retarded	NULL
complex	NULL
C1	NULL
was	NULL
observed	NULL
only	NULL
at	NULL
higher	NULL
concentrations	NULL
of	NULL
HMG-I	NULL
,	NULL
indicating	NULL
lower-affinity	NULL
interactions	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
complex	NULL
C1	NULL
was	NULL
affected	NULL
by	NULL
mutation	NULL
of	NULL
the	NULL
TATATT	NULL
sequences	NULL
located	NULL
either	NULL
at	NULL
nucleotides	NULL
-128	NULL
to	NULL
-123	NULL
(	NULL
MS	NULL
)	NULL
or	NULL
at	NULL
nucleotides	NULL
-90	NULL
to	NULL
-85	NULL
(	NULL
M6	NULL
)	NULL
,	NULL
and	NULL
mutation	NULL
of	NULL
both	NULL
these	NULL
sites	NULL
simultaneously	NULL
(	NULL
M7	NULL
)	NULL
resulted	NULL
in	NULL
the	NULL
complete	NULL
abrogation	NULL
of	NULL
complex	NULL
C1	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
-116	NULL
to	NULL
-98	NULL
poly	NULL
(	NULL
A	NULL
-T	NULL
)	NULL
run	NULL
(	NULL
M2	NULL
)	NULL
inhibited	NULL
the	NULL
formation	NULL
of	NULL
both	NULL
complexes	NULL
,	NULL
C1	NULL
and	NULL
C2	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
is	NULL
the	NULL
major	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
site	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
there	NULL
are	NULL
three	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
in	NULL
PRRII	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
that	NULL
have	NULL
various	NULL
degrees	NULL
of	NULL
affinity	NULL
for	NULL
the	NULL
protein	NULL
.	NULL

Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
can	NULL
interact	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
.	NULL

Since	NULL
it	NULL
appeared	NULL
that	NULL
both	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
were	NULL
contained	NULL
in	NULL
complex	NULL
A	NULL
,	NULL
we	NULL
investigated	NULL
if	NULL
Elf-1	NULL
could	NULL
associate	NULL
with	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
which	NULL
was	NULL
covalently	NULL
coupled	NULL
to	NULL
agarose	NULL
beads	NULL
.	NULL

Full-length	NULL
Elf-1	NULL
[	NULL
Elf	NULL
(	NULL
1-619	NULL
)	NULL
]	NULL
efficiently	NULL
bound	NULL
to	NULL
HMG-I	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
N-terminal	NULL
99	NULL
amino	NULL
acids	NULL
[	NULL
Elf	NULL
(	NULL
100-619	NULL
)	NULL
]	NULL
did	NULL
not	NULL
diminish	NULL
this	NULL
interaction	NULL
,	NULL
while	NULL
removal	NULL
of	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
343	NULL
[	NULL
Elf	NULL
(	NULL
344-619	NULL
)	NULL
]	NULL
greatly	NULL
decreased	NULL
binding	NULL
to	NULL
HMG-I	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

An	NULL
extremely	NULL
weak	NULL
signal	NULL
was	NULL
seen	NULL
with	NULL
Elf	NULL
(	NULL
344-619	NULL
)	NULL
,	NULL
but	NULL
its	NULL
significance	NULL
is	NULL
unclear	NULL
.	NULL

A	NULL
construct	NULL
containing	NULL
residues	NULL
1	NULL
to	NULL
303	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
;	NULL
however	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
conserved	NULL
Ets	NULL
homology	NULL
domain	NULL
between	NULL
amino	NULL
acids	NULL
207	NULL
and	NULL
303	NULL
(	NULL
37	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
total	NULL
abrogation	NULL
of	NULL
interaction	NULL
with	NULL
HMG-I	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
major	NULL
interaction	NULL
surface	NULL
mapping	NULL
to	NULL
the	NULL
Ets	NULL
domain	NULL
of	NULL
Elf-1	NULL
,	NULL
constructs	NULL
that	NULL
contained	NULL
amino	NULL
acids	NULL
100	NULL
to	NULL
304	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
,	NULL
151	NULL
to	NULL
303	NULL
(	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
,	NULL
and	NULL
207	NULL
to	NULL
303	NULL
(	NULL
lanes	NULL
15	NULL
and	NULL
16	NULL
)	NULL
were	NULL
all	NULL
able	NULL
to	NULL
efficiently	NULL
interact	NULL
with	NULL
HMG-I	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
specificity	NULL
of	NULL
the	NULL
Elf-1-HMG-I	NULL
interaction	NULL
,	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
IL-7	NULL
receptor	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
HMG-I	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
found	NULL
that	NULL
GST-EIlf-1	NULL
can	NULL
specifically	NULL
retain	NULL
a	NULL
Gald4-HMG-I	NULL
fusion	NULL
protein	NULL
,	NULL
but	NULL
not	NULL
Gal4	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
contaminating	NULL
DNA	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
Elf-1	NULL
can	NULL
interact	NULL
with	NULL
HMG-I	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
through	NULL
its	NULL
conserved	NULL
Ets	NULL
domain	NULL
(	NULL
residues	NULL
207	NULL
to	NULL
303	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
in	NULL
facilitating	NULL
the	NULL
binding	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
(	NULL
12	NULL
,	NULL
71	NULL
)	NULL
;	NULL
however	NULL
,	NULL
we	NULL
found	NULL
no	NULL
evidence	NULL
for	NULL
an	NULL
increase	NULL
in	NULL
Elf-1	NULL
binding	NULL
to	NULL
PRRII	NULL
when	NULL
HMG-I	NULL
was	NULL
added	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
are	NULL
essential	NULL
,	NULL
and	NULL
together	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
can	NULL
transactivate	NULL
the	NULL
-137/-64	NULL
element	NULL
in	NULL
COS-7	NULL
cells	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
and	NULL
Elf-1	NULL
in	NULL
activating	NULL
transcription	NULL
from	NULL
PRRII	NULL
,	NULL
using	NULL
cotransfection	NULL
experiments	NULL
with	NULL
COS-7	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9A	NULL
,	NULL
HMG-I	NULL
or	NULL
Elf-1	NULL
alone	NULL
weakly	NULL
transactivated	NULL
pTKa-137/-64	NULL
;	NULL
however	NULL
,	NULL
together	NULL
they	NULL
potently	NULL
increased	NULL
transcription	NULL
of	NULL
this	NULL
reporter	NULL
construct	NULL
.	NULL

This	NULL
synergistic	NULL
effect	NULL
required	NULL
intact	NULL
binding	NULL
sites	NULL
for	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
diminished	NULL
activity	NULL
of	NULL
constructs	NULL
mutated	NULL
at	NULL
either	NULL
or	NULL
both	NULL
of	NULL
these	NULL
sites	NULL
(	NULL
pTKaM1	NULL
,	NULL
pTKa	NULL
«	NULL
M2	NULL
,	NULL
and	NULL
pTKaM3	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1B	NULL
for	NULL
sequences	NULL
of	NULL
the	NULL
mutants	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
the	NULL
abilities	NULL
of	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
to	NULL
transactivate	NULL
a	NULL
mutant	NULL
construct	NULL
,	NULL
M4	NULL
or	NULL
one	NULL
in	NULL
which	NULL
only	NULL
the	NULL
two	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
sites	NULL
identified	NULL
by	NULL
DNase	NULL
I	NULL
(	NULL
-128	NULL
to	NULL
-123	NULL
and	NULL
-116	NULL
to	NULL
-98	NULL
)	NULL
were	NULL
mutated	NULL
,	NULL
and	NULL
obtained	NULL
results	NULL
similar	NULL
to	NULL
those	NULL
with	NULL
M2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Elf-1	NULL
bound	NULL
to	NULL
mutants	NULL
M2	NULL
and	NULL
M4	NULL
at	NULL
levels	NULL
1792	NULL
JOHN	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

AN	NULL
N	NULL
m	NULL
ml	NULL
A	NULL
N®	NULL
035.9	NULL
“	NULL
69	NULL
06	NULL
>	NULL
é	NULL
)	NULL
0:50	NULL
“	NULL
~	NULL
Qn	NULL
``	NULL
a	NULL
'	NULL
6g	NULL
&	NULL
C	NULL
C	NULL
0	NULL
,	NULL
_	NULL
Co	NULL
,	NULL
C	NULL
.	NULL

@	NULL
«	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
*	NULL
&	NULL
_	NULL
=	NULL
&	NULL
&	NULL
&	NULL
5	NULL
60	NULL
po	NULL
56	NULL
5	NULL
o	NULL
-	NULL
bo	NULL
bo	NULL
P6	NULL
5	NULL
5	NULL
=	NULL
=	NULL
=	NULL
=	NULL
=	NULL
=	NULL
=	NULL
3	NULL
=	NULL
kDa	NULL
€	NULL
T	NULL
€	NULL
I	NULL
<	NULL
2	NULL
I	NULL
kDa	NULL
<	NULL
I	NULL
<	NULL
T	NULL
2	NULL
I	NULL
<	NULL
I	NULL
kDa	NULL
2	NULL
T	NULL
200	NULL
-	NULL
200	NULL
-	NULL
46-97	NULL
-	NULL
14—	NULL
g	NULL
;	NULL
=	NULL
30-	NULL
__	NULL
§§	NULL
-	NULL
28	NULL
-	NULL
t	NULL
»	NULL
a-	NULL
a	NULL
22	NULL
--	NULL
<	NULL
-	NULL
30	NULL
-	NULL
14-	NULL
``	NULL
-B	NULL
#	NULL
22—	NULL
'	NULL
€	NULL
C	NULL
#	NULL
m	NULL
--	NULL
``	NULL
L	NULL
.-1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
‘	NULL
15	NULL
16	NULL
HMG-I	NULL
B	NULL
Ets	NULL
domain	NULL
Interaction	NULL
Elf	NULL
1-619	NULL
C	NULL
moony	NULL
=	NULL
1	NULL
+	NULL
Elf	NULL
1-303	NULL
C	NULL
--	NULL
~~	NULL
-as	NULL
+	NULL
Elf	NULL
1-206	NULL
=	NULL
Elf	NULL
100-304	NULL
+	NULL
Elf	NULL
151-303	NULL
C-	NULL
+	NULL
Elf	NULL
207-303	NULL
Ex	NULL
+	NULL
Elf	NULL
100-619	NULL
c	NULL
+	NULL
Elf	NULL
344-619	NULL
C	NULL
--	NULL
--	NULL
--	NULL
-I3	NULL
+/-	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

The	NULL
Ets	NULL
domain	NULL
of	NULL
Elf-1	NULL
mediates	NULL
its	NULL
interaction	NULL
with	NULL
HMG-I	NULL
.	NULL

*°S-labeled	NULL
N-	NULL
and	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
Elf-1	NULL
were	NULL
produced	NULL
by	NULL
in	NULL
vitro	NULL
transcription-translation	NULL
reactions	NULL
and	NULL
incubated	NULL
with	NULL
HMG-I	NULL
coupled	NULL
to	NULL
Sepharose	NULL
beads	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
bound	NULL
Elf-1	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Odd	NULL
lanes	NULL
,	NULL
amounts	NULL
of	NULL
input	NULL
proteins	NULL
;	NULL
even	NULL
lanes	NULL
,	NULL
bound	NULL
proteins	NULL
.	NULL

The	NULL
protein	NULL
products	NULL
expected	NULL
in	NULL
each	NULL
case	NULL
are	NULL
indicated	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
Elf-1	NULL
derivatives	NULL
and	NULL
summary	NULL
of	NULL
the	NULL
interaction	NULL
results	NULL
.	NULL

+	NULL
,	NULL
specific	NULL
interaction	NULL
;	NULL
-	NULL
,	NULL
no	NULL
specific	NULL
interaction	NULL
;	NULL
+/-	NULL
,	NULL
very	NULL
weak	NULL
interaction	NULL
.	NULL

similar	NULL
to	NULL
those	NULL
for	NULL
the	NULL
wild-type	NULL
-137/-64	NULL
oligonucleotide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
a	NULL
functional	NULL
coopera-tivity	NULL
between	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
from	NULL
PRRIL	NULL
Corresponding	NULL
to	NULL
these	NULL
results	NULL
with	NULL
COS	NULL
cells	NULL
,	NULL
the	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
were	NULL
required	NULL
for	NULL
maximal	NULL
activity	NULL
of	NULL
the	NULL
-472	NULL
to	NULL
+109	NULL
IL-2Ra	NULL
promoter	NULL
construct	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
the	NULL
Elf-1	NULL
binding	NULL
site	NULL
(	NULL
IL-2R	NULL
«	NULL
M1	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
or	NULL
the	NULL
dominant	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
site	NULL
(	NULL
IL-2R	NULL
«	NULL
M4	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
significantly	NULL
decreased	NULL
the	NULL
overall	NULL
levels	NULL
of	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

Analogous	NULL
mutations	NULL
in	NULL
pTKa-137/-64	NULL
also	NULL
resulted	NULL
in	NULL
decreased	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
Elf-1	NULL
site	NULL
profoundly	NULL
diminished	NULL
IL-Z2Ra	NULL
promoter	NULL
activity	NULL
,	NULL
even	NULL
when	NULL
the	NULL
-276	NULL
to	NULL
-244	NULL
upstream	NULL
enhancer	NULL
(	NULL
PRRI	NULL
)	NULL
was	NULL
intact	NULL
,	NULL
indicates	NULL
the	NULL
existence	NULL
of	NULL
important	NULL
functional	NULL
interactions	NULL
between	NULL
Elf-1	NULL
and	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
PRRL	NULL
Elf-1	NULL
interacts	NULL
with	NULL
p50	NULL
and	NULL
c-Rel	NULL
proteins	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
.	NULL

Since	NULL
both	NULL
PRRI	NULL
and	NULL
PRRII	NULL
are	NULL
essential	NULL
for	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
speculated	NULL
that	NULL
these	NULL
regions	NULL
functionally	NULL
coordinate	NULL
with	NULL
each	NULL
other	NULL
via	NULL
interactions	NULL
between	NULL
Elf-1	NULL
and	NULL
a	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
binds	NULL
to	NULL
PRRI	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10A	NULL
,	NULL
GST-Elf-1	NULL
bound	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
c-Rel	NULL
contained	NULL
in	NULL
MT-2	NULL
T-cell	NULL
extracts	NULL
but	NULL
not	NULL
the	NULL
p105	NULL
precursor	NULL
form	NULL
of	NULL
p50	NULL
.	NULL

We	NULL
obtained	NULL
similar	NULL
results	NULL
with	NULL
in	NULL
vitro-translated	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
,	NULL
lanes	NULL
6	NULL
,	NULL
9	NULL
,	NULL
and	NULL
12	NULL
)	NULL
and	NULL
additionally	NULL
demonstrated	NULL
that	NULL
GST-EIf-1	NULL
did	NULL
not	NULL
interact	NULL
with	NULL
NF-kB	NULL
p65	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
SRF	NULL
(	NULL
lane	NULL
15	NULL
)	NULL
at	NULL
the	NULL
concentrations	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

The	NULL
interactions	NULL
of	NULL
Elf-1	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
c-Rel	NULL
were	NULL
not	NULL
mediated	NULL
by	NULL
contaminating	NULL
DNA	NULL
,	NULL
since	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ethidium	NULL
bromide	NULL
.	NULL

We	NULL
consistently	NULL
observed	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
retained	NULL
by	NULL
GST-EIf	NULL
columns	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HMG-I	NULL
,	NULL
consistent	NULL
with	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
acting	NULL
as	NULL
``	NULL
molecular	NULL
glue	NULL
``	NULL
between	NULL
Elf-1	NULL
and	NULL
NF-kB	NULL
p50	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
confirmed	NULL
the	NULL
interaction	NULL
of	NULL
Elf-1	NULL
with	NULL
c-Rel	NULL
but	NULL
not	NULL
p65	NULL
by	NULL
coprecipitation	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

10C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
provocative	NULL
in	NULL
view	NULL
of	NULL
the	NULL
suggestion	NULL
that	NULL
c-Rel	NULL
and	NULL
NF-kB	NULL
p50	NULL
synergize	NULL
to	NULL
activate	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
during	NULL
T-cell	NULL
activation	NULL
(	NULL
69	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
region	NULL
of	NULL
Elf-1	NULL
necessary	NULL
for	NULL
interaction	NULL
with	NULL
c-Rel	NULL
,	NULL
N-	NULL
and	NULL
C-terminal	NULL
deletion	NULL
constructs	NULL
were	NULL
labeled	NULL
with	NULL
3°S-methionine	NULL
by	NULL
in	NULL
vitro	NULL
transcription-translation	NULL
and	NULL
evaluated	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
associate	NULL
with	NULL
c-Rel	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
300	NULL
)	NULL
coupled	NULL
to	NULL
agarose	NULL
beads	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
10D	NULL
,	NULL
full-length	NULL
Elf-1	NULL
protein	NULL
[	NULL
Elf	NULL
(	NULL
1-619	NULL
)	NULL
]	NULL
associated	NULL
with	NULL
c-Rel	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
either	NULL
the	NULL
N-terminal	NULL
100	NULL
amino	NULL
acids	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
did	NULL
not	NULL
abrogate	NULL
interaction	NULL
with	NULL
c-Rel	NULL
.	NULL

Truncated	NULL
Elf-1	NULL
proteins	NULL
that	NULL
contained	NULL
only	NULL
residues	NULL
100	NULL
to	NULL
304	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
or	NULL
207	NULL
to	NULL
303	NULL
,	NULL
the	NULL
Ets	NULL
domain	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
,	NULL
could	NULL
still	NULL
bind	NULL
,	NULL
while	NULL
deletion	NULL
of	NULL
the	NULL
Ets	NULL
domain	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
prevented	NULL
interaction	NULL
with	NULL
c-Rel	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
highly	NULL
conserved	NULL
Ets	NULL
domain	NULL
of	NULL
Elf-1	NULL
appears	NULL
to	NULL
be	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
its	NULL
interaction	NULL
with	NULL
c-Rel	NULL
as	NULL
well	NULL
as	NULL
with	NULL
HMG-IL	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
delineated	NULL
a	NULL
novel	NULL
regulatory	NULL
element	NULL
(	NULL
PRRI	NULL
)	NULL
essential	NULL
for	NULL
IL-Z2Ra	NULL
«	NULL
gene	NULL
expression	NULL
.	NULL

Unlike	NULL
the	NULL
previously	NULL
defined	NULL
-299	NULL
to	NULL
-228	NULL
upstream	NULL
enhancer	NULL
(	NULL
PRRI	NULL
)	NULL
,	NULL
PRRII	NULL
is	NULL
more	NULL
strictly	NULL
conserved	NULL
between	NULL
mice	NULL
and	NULL
humans	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
bound	NULL
to	NULL
PRRII	NULL
in	NULL
an	NULL
inducible	NULL
manner	NULL
.	NULL

Although	NULL
inducible	NULL
Elf-1	NULL
binding	NULL
to	NULL
other	NULL
promoter	NULL
regions	NULL
has	NULL
been	NULL
observed	NULL
(	NULL
22	NULL
,	NULL
78	NULL
,	NULL
81	NULL
)	NULL
,	NULL
to	NULL
our	NULL
knowledge	NULL
this	NULL
is	NULL
the	NULL
first	NULL
demonstration	NULL
of	NULL
mitogen-induced	NULL
binding	NULL
of	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
to	NULL
DNA	NULL
.	NULL

This	NULL
finding	NULL
may	NULL
be	NULL
physiologically	NULL
sig-	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
A	NULL
aa	NULL
~a	NULL
o	NULL
Pu	NULL
o	NULL
0	NULL
RELATIVE	NULL
CAT	NULL
ACTIVITY	NULL
8	NULL
0	NULL
pTKo-137/-64	NULL
+	NULL
+	NULL
+	NULL
+	NULL
pTKe	NULL
M1	NULL
pTKo	NULL
:	NULL
.	NULL

M2	NULL
pTKe	NULL
.	NULL

M3	NULL
vector	NULL
Effectorl	NULL
:	NULL
Elf	NULL
HMG	NULL
-I	NULL
1	NULL
I	NULL
U	NULL
U	NULL
+	NULL
Reporter	NULL
+04	NULL
d	NULL
d	NULL
bob	NULL
lod	NULL
1	NULL
U	NULL
1	NULL
U	NULL
1	NULL
1	NULL
t	NULL
4	NULL
lod	NULL
+	NULL
1	NULL
+	NULL
+	NULL
+	NULL
+	NULL
I	NULL
+	NULL
1	NULL
O1	NULL
+	NULL
I	NULL
U	NULL
U	NULL
U	NULL
1	NULL
1	NULL
U	NULL
1	NULL
B	NULL
50	NULL
[	NULL
C	NULL
]	NULL
UNINDUCED	NULL
N	NULL
PMA	NULL
INDUCED	NULL
40	NULL
30	NULL
20	NULL
10	NULL
RELATIVE	NULL
CAT	NULL
ACTIVITY	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Functional	NULL
significance	NULL
of	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
for	NULL
IL-2R	NULL
«	NULL
gene	NULL
regulation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
are	NULL
required	NULL
for	NULL
maximal	NULL
transcription	NULL
from	NULL
the	NULL
-137/-64	NULL
element	NULL
in	NULL
COS-7	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
are	NULL
means	NULL
and	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
derived	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
relevant	NULL
reporter	NULL
and	NULL
effector	NULL
plasmids	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
pTKa-137/-64	NULL
cotransfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1	NULL
,	NULL
and	NULL
all	NULL
other	NULL
values	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
increase	NULL
over	NULL
this	NULL
value	NULL
.	NULL

In	NULL
addition	NULL
the	NULL
activities	NULL
of	NULL
pTKa	NULL
«	NULL
M1	NULL
,	NULL
pTK	NULL
«	NULL
M2	NULL
,	NULL
and	NULL
pTKaM3	NULL
cotransfected	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
were	NULL
subtracted	NULL
from	NULL
the	NULL
values	NULL
obtained	NULL
for	NULL
cotransfection	NULL
with	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
for	NULL
each	NULL
of	NULL
these	NULL
reporter	NULL
plasmids	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
IL-2Re	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
mutant	NULL
promoter	NULL
-472	NULL
to	NULL
+109	NULL
IL-2Ra-CAT	NULL
reporter	NULL
con-structs	NULL
.	NULL

JO	NULL
,	NULL
control	NULL
plasmid	NULL
JYMCAT-0	NULL
.	NULL

The	NULL
M1	NULL
and	NULL
M4	NULL
mutations	NULL
in	NULL
IL-2ReM1	NULL
and	NULL
IL-2ReM4	NULL
are	NULL
defined	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

The	NULL
data	NULL
are	NULL
means	NULL
and	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
JO	NULL
without	NULL
PMA	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
1	NULL
,	NULL
and	NULL
all	NULL
other	NULL
activities	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
increase	NULL
over	NULL
this	NULL
value	NULL
.	NULL

nificant	NULL
given	NULL
that	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
gene	NULL
is	NULL
stimulated	NULL
by	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Whereas	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
proteins	NULL
are	NULL
widely	NULL
expressed	NULL
(	NULL
14	NULL
)	NULL
,	NULL
Elf-1	NULL
is	NULL
lymphoid	NULL
tissue	NULL
specific	NULL
(	NULL
72	NULL
)	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
its	NULL
playing	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
cell-type-specific	NULL
expression	NULL
of	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
.	NULL

Although	NULL
Elf-1	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
other	NULL
T-cell-specific	NULL
genes	NULL
(	NULL
22	NULL
,	NULL
78	NULL
,	NULL
81	NULL
)	NULL
,	NULL
this	NULL
study	NULL
is	NULL
the	NULL
first	NULL
to	NULL
demonstrate	NULL
direct	NULL
activation	NULL
of	NULL
a	NULL
gene	NULL
by	NULL
overexpression	NULL
of	NULL
Elf-1	NULL
.	NULL

Interestingly	NULL
,	NULL
transfection	NULL
of	NULL
Elf-1	NULL
alone	NULL
was	NULL
insufficient	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
PRRII	NULL
in	NULL
COS-7	NULL
cells	NULL
,	NULL
even	NULL
though	NULL
these	NULL
cells	NULL
contain	NULL
endogenous	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
threshold	NULL
level	NULL
of	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
is	NULL
required	NULL
.	NULL

The	NULL
synergy	NULL
between	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
many	NULL
Ets	NULL
family	NULL
proteins	NULL
activate	NULL
transcription	NULL
in	NULL
conjunction	NULL
with	NULL
other	NULL
proteins	NULL
(	NULL
9	NULL
,	NULL
13	NULL
,	NULL
27	NULL
,	NULL
73	NULL
)	NULL
.	NULL

IL-2R	NULL
«	NULL
EXPRESSION	NULL
1793	NULL
In	NULL
contrast	NULL
to	NULL
the	NULL
situation	NULL
with	NULL
the	NULL
beta	NULL
interferon	NULL
gene	NULL
promoter	NULL
,	NULL
in	NULL
which	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
proteins	NULL
facilitate	NULL
the	NULL
binding	NULL
of	NULL
transcriptional	NULL
activator	NULL
proteins	NULL
to	NULL
DNA	NULL
(	NULL
12	NULL
,	NULL
71	NULL
)	NULL
,	NULL
we	NULL
have	NULL
found	NULL
no	NULL
evidence	NULL
for	NULL
augmented	NULL
Elf-1	NULL
binding	NULL
to	NULL
PRRII	NULL
by	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
.	NULL

However	NULL
,	NULL
both	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
same	NULL
complex	NULL
in	NULL
EMSAs	NULL
and	NULL
can	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNA	NULL
.	NULL

The	NULL
Ets	NULL
domain	NULL
of	NULL
Elf-1	NULL
was	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
mediate	NULL
its	NULL
interaction	NULL
with	NULL
HMG-I	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
interaction	NULL
with	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
may	NULL
allow	NULL
Elf-1	NULL
to	NULL
maintain	NULL
a	NULL
transcriptionally	NULL
active	NULL
conformation	NULL
.	NULL

Another	NULL
function	NULL
of	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
in	NULL
this	NULL
scenario	NULL
could	NULL
be	NULL
to	NULL
act	NULL
as	NULL
molecular	NULL
glue	NULL
in	NULL
bridging	NULL
interactions	NULL
between	NULL
Elf-1	NULL
and	NULL
NF-kB	NULL
and	NULL
perhaps	NULL
with	NULL
other	NULL
DNA-binding	NULL
proteins	NULL
that	NULL
bind	NULL
in	NULL
the	NULL
immediate	NULL
vicinity	NULL
.	NULL

Furthermore	NULL
,	NULL
its	NULL
ability	NULL
to	NULL
bend	NULL
DNA	NULL
(	NULL
36	NULL
)	NULL
could	NULL
also	NULL
facilitate	NULL
protein-protein	NULL
interactions	NULL
,	NULL
thereby	NULL
promoting	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
active	NULL
transcription	NULL
complex	NULL
.	NULL

PRRI	NULL
contains	NULL
a	NULL
xB	NULL
site	NULL
that	NULL
plays	NULL
an	NULL
important	NULL
functional	NULL
role	NULL
for	NULL
IL-2R	NULL
«	NULL
expression	NULL
in	NULL
normal	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
46	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
in	NULL
HTLV-I-transformed	NULL
MT-2	NULL
cells	NULL
(	NULL
75	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
deletion	NULL
or	NULL
mutation	NULL
of	NULL
the	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
in	NULL
PRRII	NULL
greatly	NULL
diminished	NULL
promoter	NULL
activity	NULL
even	NULL
when	NULL
the	NULL
highly	NULL
inducible	NULL
PRRI	NULL
was	NULL
intact	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
possibility	NULL
that	NULL
protein-protein	NULL
interactions	NULL
coordinate	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
PRRI	NULL
and	NULL
PRRII	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
this	NULL
idea	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
Elf-1	NULL
can	NULL
interact	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
c-Rel	NULL
,	NULL
both	NULL
of	NULL
which	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
IL-Z2Ra	NULL
«	NULL
gene	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
Elf-1	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
is	NULL
modestly	NULL
enhanced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
which	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
associate	NULL
with	NULL
NF-kB	NULL
p50	NULL
(	NULL
12	NULL
,	NULL
71	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
Elf-1	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
selective	NULL
binding	NULL
and	NULL
stabilization	NULL
of	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
proteins	NULL
to	NULL
PRRI	NULL
during	NULL
the	NULL
course	NULL
of	NULL
T-cell	NULL
activation	NULL
.	NULL

Elf-1	NULL
can	NULL
interact	NULL
with	NULL
NF-kB	NULL
p50	NULL
but	NULL
not	NULL
its	NULL
precursor	NULL
p105	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
interaction	NULL
interface	NULL
is	NULL
masked	NULL
in	NULL
p105	NULL
.	NULL

Elf-1	NULL
is	NULL
the	NULL
first	NULL
Ets	NULL
family	NULL
protein	NULL
now	NULL
known	NULL
to	NULL
interact	NULL
with	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
a	NULL
finding	NULL
that	NULL
may	NULL
have	NULL
direct	NULL
implications	NULL
for	NULL
other	NULL
Elf-1	NULL
regulated	NULL
genes	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Mapping	NULL
of	NULL
the	NULL
interaction	NULL
surface	NULL
of	NULL
Elf-1	NULL
with	NULL
c-Rel	NULL
revealed	NULL
that	NULL
,	NULL
as	NULL
with	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
the	NULL
Ets	NULL
domain	NULL
was	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
mediate	NULL
this	NULL
interaction	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
highly	NULL
conserved	NULL
Ets	NULL
domain	NULL
may	NULL
be	NULL
a	NULL
common	NULL
interaction	NULL
surface	NULL
generating	NULL
multiple	NULL
protein-protein	NULL
interactions	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
this	NULL
theme	NULL
,	NULL
we	NULL
hypothesize	NULL
that	NULL
other	NULL
specific	NULL
Ets	NULL
family	NULL
proteins	NULL
may	NULL
also	NULL
interact	NULL
with	NULL
NF-kB	NULL
family	NULL
proteins	NULL
,	NULL
thus	NULL
providing	NULL
a	NULL
mechanism	NULL
for	NULL
generating	NULL
further	NULL
diversity	NULL
in	NULL
inducible	NULL
gene	NULL
expression	NULL
in	NULL
these	NULL
situations	NULL
.	NULL

Indeed	NULL
,	NULL
our	NULL
preliminary	NULL
studies	NULL
with	NULL
the	NULL
Ets	NULL
domain	NULL
of	NULL
another	NULL
member	NULL
of	NULL
this	NULL
family	NULL
of	NULL
proteins	NULL
indicates	NULL
that	NULL
it	NULL
can	NULL
also	NULL
interact	NULL
with	NULL
NF-kB	NULL
family	NULL
proteins	NULL
in	NULL
vitro	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
mitogen-stimulated	NULL
expression	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
requires	NULL
coordinated	NULL
interactions	NULL
between	NULL
multiple	NULL
regulatory	NULL
proteins	NULL
.	NULL

The	NULL
model	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

11	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
data	NULL
and	NULL
is	NULL
somewhat	NULL
analogous	NULL
to	NULL
models	NULL
proposed	NULL
for	NULL
the	NULL
T-cell	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
and	NULL
beta	NULL
interferon	NULL
genes	NULL
,	NULL
in	NULL
which	NULL
HMG	NULL
proteins	NULL
architecturally	NULL
facilitate	NULL
the	NULL
formation	NULL
of	NULL
stereospecific	NULL
enhancer	NULL
complexes	NULL
(	NULL
5	NULL
,	NULL
19	NULL
,	NULL
20	NULL
,	NULL
23	NULL
,	NULL
74	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
these	NULL
other	NULL
systems	NULL
,	NULL
however	NULL
,	NULL
cell-type-specific	NULL
regulation	NULL
and	NULL
inducible	NULL
IL-2Ra	NULL
regulation	NULL
involve	NULL
interactions	NULL
not	NULL
only	NULL
between	NULL
adjacent	NULL
proteins	NULL
within	NULL
a	NULL
single	NULL
transcriptional	NULL
regulatory	NULL
domain	NULL
but	NULL
also	NULL
between	NULL
two	NULL
spatially	NULL
separated	NULL
transcriptional	NULL
regulatory	NULL
domains	NULL
,	NULL
presumably	NULL
resulting	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
highly	NULL
specific	NULL
nucleoprotein	NULL
complex	NULL
.	NULL

It	NULL
seems	NULL
likely	NULL
that	NULL
PRRII	NULL
contributes	NULL
more	NULL
towards	NULL
basal	NULL
promoter	NULL
activity	NULL
and	NULL
cell	NULL
type	NULL
specificity	NULL
of	NULL
expression	NULL
whereas	NULL
PRRI	NULL
1794	NULL
JOHN	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

B	NULL
o	NULL
p	NULL
&	NULL
$	NULL
n	NULL
A	NULL
Qﬁ	NULL
?	NULL

&	NULL
A90	NULL
&	NULL
©	NULL
C	NULL
6	NULL
hss	NULL
&	NULL
&	NULL
&	NULL
&	NULL
QxQﬁ	NULL
MT-2	NULL
CELL	NULL
a	NULL
E04	NULL
©	NULL
i	NULL
As	NULL
LYSATE	NULL
Eo	NULL
Wop	NULL
§	NULL
b	NULL
©	NULL
-o	NULL
&	NULL
i-	NULL
d	NULL
6°	NULL
&	NULL
~5-~	NULL
aks	NULL
<	NULL
bh	NULL
555	NULL
255	NULL
i	NULL
.	NULL

5	NULL
,	NULL
cre	NULL
wid	NULL
200	NULL
Zuo	NULL
$	NULL
00	NULL
288	NULL
288	NULL
ip	NULL
anti-ELF	NULL
E	NULL
t	NULL
kDa	NULL
kDa	NULL
kDa	NULL
25	NULL
5	NULL
200	NULL
-	NULL
$	NULL
_	NULL
kDa	NULL
a	NULL
G	NULL
G	NULL
200	NULL
-+	NULL
200	NULL
200	NULL
NFB	NULL
p105-	NULL
»	NULL
1-2	NULL
*	NULL
23	NULL
``	NULL
.	NULL

®	NULL
97	NULL
-	NULL
p	NULL
»	NULL
E	NULL
97-	NULL
f	NULL
a	NULL
-	NULL
-	NULL
is	NULL
B	NULL
_	NULL
p	NULL
®	NULL
=	NULL
68-	NULL
_	NULL
97	NULL
~	NULL
W	NULL
a-c-Rel	NULL
as	NULL
-	NULL
®	NULL
68	NULL
-	NULL
pm	NULL
w	NULL
_	NULL
NF-cB	NULL
pso	NULL
/	NULL
-	NULL
»	NULL
4	NULL
*	NULL
-	NULL
KR	NULL
a6~	NULL
«	NULL
-	NULL
¥	NULL
30	NULL
-	NULL
cso	NULL
NF-cB	NULL
c-Rel-	NULL
»	NULL
@	NULL
@	NULL
-1	NULL
!	NULL

2	NULL
3	NULL
4	NULL
56	NULL
98	NULL
a	NULL
0	NULL
30	NULL
--	NULL
131415	NULL
t	NULL
-	NULL
4	NULL
,	NULL
10	NULL
1112	NULL
A	NULL
a	NULL
&	NULL
A	NULL
c-Rel	NULL
D	NULL
$	NULL
58	NULL
“	NULL
$	NULL
9	NULL
$	NULL
®	NULL
Ne	NULL
“	NULL
?	NULL

get	NULL
)	NULL
E	NULL
Ets	NULL
domain	NULL
Interaction	NULL
«	NULL
Q	NULL
«	NULL
Q	NULL
«	NULL
(	NULL
5	NULL
«	NULL
(	NULL
e	NULL
$	NULL
\	NULL
«	NULL
Q	NULL
Elf	NULL
1-619	NULL
C	NULL
-1	NULL
+	NULL
&	NULL
y	NULL
&	NULL
y	NULL
&	NULL
&	NULL
a	NULL
~	NULL
ma	NULL
Elf	NULL
1-303	NULL
--	NULL
--	NULL
--	NULL
--	NULL
maas	NULL
+	NULL
5	NULL
a	NULL
G	NULL
€	NULL
6	NULL
€	NULL
e	NULL
Pe	NULL
$	NULL
.	NULL

LE	NULL
L8	NULL
.E	NULL
LE	NULL
Elf	NULL
1-206	NULL
C	NULL
--	NULL
--	NULL
--	NULL
-3	NULL
a82	NULL
-	NULL
sf	NULL
aB	NULL
asf	NULL
si	NULL
:	NULL
2	NULL
$	NULL
Elf	NULL
100-304	NULL
--	NULL
r	NULL
+	NULL
2	NULL
6	NULL
246	NULL
24	NULL
240	NULL
24	NULL
2	NULL
%	NULL
kDa	NULL
kDa	NULL
``	NULL
``	NULL
kDa	NULL
Elf	NULL
207-303	NULL
+	NULL
200	NULL
-	NULL
200	NULL
-	NULL
WB	NULL
is	NULL
E	NULL
W	NULL
or	NULL
-	NULL
®	NULL
30-	NULL
_	NULL
_	NULL
Elf	NULL
100-619	NULL
--	NULL
-	NULL
4	NULL
+	NULL
*	NULL
``	NULL
68	NULL
-	NULL
(	NULL
Erl	NULL
~	NULL
Elf	NULL
344-619	NULL
``	NULL
-m	NULL
~*	NULL
as-	NULL
<	NULL
8	NULL
m	NULL
Q	NULL
*-as	NULL
-M	NULL
©	NULL
+	NULL
25°	NULL
€	NULL
30	NULL
-	NULL
wa	NULL
«	NULL
-=	NULL
&	NULL
~-	NULL
11	NULL
12	NULL
12	NULL
a	NULL
4	NULL
£6	NULL
7s	NULL
a	NULL
10	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Elf-1	NULL
physically	NULL
associates	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
c-Rel	NULL
but	NULL
not	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
p105	NULL
,	NULL
or	NULL
SRF	NULL
.	NULL

(	NULL
A	NULL
)	NULL
MT-2	NULL
T-cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
GST-Elf-1	NULL
or	NULL
GST	NULL
immobilized	NULL
to	NULL
glutathione-Sepharose	NULL
beads	NULL
.	NULL

Lane	NULL
1	NULL
contains	NULL
one-fifth	NULL
of	NULL
the	NULL
input	NULL
cell	NULL
extract	NULL
.	NULL

The	NULL
specifically	NULL
retained	NULL
products	NULL
were	NULL
visualized	NULL
with	NULL
a	NULL
c-Rel	NULL
antibody	NULL
or	NULL
an	NULL
anti-N-terminal	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
antibody	NULL
,	NULL
which	NULL
can	NULL
immunoprecipitate	NULL
both	NULL
p30	NULL
and	NULL
its	NULL
precursor	NULL
,	NULL
p105	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
vitro-translated	NULL
*°S-labeled	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p105	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
SRF	NULL
were	NULL
incubated	NULL
with	NULL
GST	NULL
or	NULL
GST-Elf-1	NULL
immobilized	NULL
on	NULL
glutathione-Sepharose	NULL
beads	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
control	NULL
experiments	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
400	NULL
ug	NULL
of	NULL
ethidium	NULL
bromide	NULL
per	NULL
ml	NULL
.	NULL

(	NULL
C	NULL
)	NULL
MT-2	NULL
T-cell	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
Elf-1	NULL
,	NULL
and	NULL
the	NULL
coprecipitated	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
immunoblotting	NULL
)	NULL
using	NULL
antibodies	NULL
to	NULL
c-Rel	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
heavy-chain	NULL
and	NULL
c-Rel	NULL
bands	NULL
are	NULL
indicated	NULL
.	NULL

Similar	NULL
experiments	NULL
to	NULL
detect	NULL
the	NULL
coprecipitation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
with	NULL
Elf-1	NULL
were	NULL
difficult	NULL
to	NULL
evaluate	NULL
since	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
band	NULL
was	NULL
expected	NULL
to	NULL
be	NULL
superimposed	NULL
on	NULL
the	NULL
heavy-chain	NULL
signal	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Identification	NULL
of	NULL
the	NULL
domain	NULL
of	NULL
interaction	NULL
of	NULL
Elf-1	NULL
with	NULL
c-Rel	NULL
.	NULL

In	NULL
vitro-translated	NULL
*°S-labeled	NULL
deletion	NULL
mutants	NULL
of	NULL
Elf-1	NULL
were	NULL
incubated	NULL
with	NULL
c-Rel	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
300	NULL
)	NULL
coupled	NULL
to	NULL
agarose	NULL
.	NULL

The	NULL
bound	NULL
Elf-1	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

Odd	NULL
lanes	NULL
,	NULL
amounts	NULL
of	NULL
input	NULL
proteins	NULL
;	NULL
even	NULL
lanes	NULL
,	NULL
bound	NULL
proteins	NULL
.	NULL

The	NULL
expected	NULL
protein	NULL
products	NULL
are	NULL
indicated	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Schematic	NULL
diagram	NULL
of	NULL
the	NULL
Elf-1	NULL
derivatives	NULL
and	NULL
summary	NULL
of	NULL
the	NULL
interaction	NULL
with	NULL
c-Rel	NULL
.	NULL

+	NULL
,	NULL
specific	NULL
interaction	NULL
;	NULL
-	NULL
,	NULL
no	NULL
specific	NULL
interaction	NULL
.	NULL

ACTIVATED	NULL
T-CELLS	NULL
RESTING	NULL
T-CELLS	NULL
pag	NULL
:	NULL
___	NULL
email	NULL
__	NULL
[	NULL
xe	NULL
L_	NULL
]	NULL
L_____	NULL
]	NULL
©	NULL
nmo-1	NULL
(	NULL
v	NULL
morecutes	NULL
FIG	NULL
.	NULL

11	NULL
.	NULL

Model	NULL
of	NULL
the	NULL
IL-2R	NULL
«	NULL
promoter	NULL
before	NULL
(	NULL
resting	NULL
T	NULL
cells	NULL
)	NULL
and	NULL
after	NULL
(	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
mitogen	NULL
stimulation	NULL
depicting	NULL
direct	NULL
interactions	NULL
between	NULL
NFxB	NULL
,	NULL
Elf-1	NULL
,	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
.	NULL

Two	NULL
schematics	NULL
are	NULL
depicted	NULL
for	NULL
the	NULL
activated	NULL
state	NULL
;	NULL
the	NULL
upper	NULL
schematic	NULL
depicts	NULL
direct	NULL
Elf-1-NF	NULL
«	NULL
B	NULL
interactions	NULL
,	NULL
whereas	NULL
the	NULL
lower	NULL
schematic	NULL
additionally	NULL
shows	NULL
the	NULL
possibility	NULL
that	NULL
HMG-I	NULL
may	NULL
enhance	NULL
the	NULL
Elf-1-NF-	NULL
«	NULL
B	NULL
p50	NULL
interaction	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
both	NULL
models	NULL
depicting	NULL
the	NULL
activated	NULL
state	NULL
exist	NULL
at	NULL
the	NULL
same	NULL
time	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
three	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

7C	NULL
,	NULL
we	NULL
have	NULL
evidence	NULL
for	NULL
a	NULL
fourth	NULL
site	NULL
between	NULL
nucleotides	NULL
-183	NULL
and	NULL
-153	NULL
;	NULL
hence	NULL
,	NULL
four	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
molecules	NULL
are	NULL
shown	NULL
contacting	NULL
DNA	NULL
.	NULL

Although	NULL
no	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
is	NULL
shown	NULL
bound	NULL
to	NULL
the	NULL
promoter	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
believe	NULL
that	NULL
there	NULL
is	NULL
some	NULL
binding	NULL
to	NULL
the	NULL
major	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
site	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
more	NULL
potently	NULL
contributes	NULL
to	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
IL-2Ra	NULL
gene	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
showing	NULL
that	NULL
mutation	NULL
of	NULL
the	NULL
Elf-1	NULL
site	NULL
significantly	NULL
diminishes	NULL
transcriptional	NULL
activity	NULL
but	NULL
has	NULL
a	NULL
minimal	NULL
effect	NULL
on	NULL
the	NULL
PMA	NULL
inducibility	NULL
of	NULL
the	NULL
construct	NULL
.	NULL

Since	NULL
the	NULL
IL-2Ra	NULL
«	NULL
gene	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
unstimulated	NULL
normal	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
hypothesize	NULL
that	NULL
the	NULL
constitutive	NULL
activity	NULL
of	NULL
PRRII	NULL
in	NULL
Jurkat	NULL
cells	NULL
reflects	NULL
the	NULL
endogenous	NULL
levels	NULL
of	NULL
Elf-1	NULL
and	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
in	NULL
Jurkat	NULL
cells	NULL
whereas	NULL
no	NULL
Elf-1	NULL
is	NULL
found	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
two-	NULL
to	NULL
threefold	NULL
inducibility	NULL
of	NULL
PRRII	NULL
in	NULL
Jurkat	NULL
cells	NULL
results	NULL
from	NULL
posttranslational	NULL
modification	NULL
(	NULL
s	NULL
)	NULL
of	NULL
Elf-1	NULL
.	NULL

PRRII	NULL
also	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
coordinating	NULL
and	NULL
amplifying	NULL
signals	NULL
received	NULL
from	NULL
other	NULL
parts	NULL
of	NULL
the	NULL
promoter	NULL
since	NULL
a	NULL
point	NULL
mutation	NULL
in	NULL
the	NULL
Elf-1	NULL
binding	NULL
site	NULL
is	NULL
sufficient	NULL
to	NULL
abrogate	NULL
transcription	NULL
from	NULL
the	NULL
IL-2Ra	NULL
«	NULL
promoter	NULL
.	NULL

In	NULL
this	NULL
re-gard	NULL
,	NULL
it	NULL
is	NULL
relevant	NULL
that	NULL
Elf-1	NULL
can	NULL
bind	NULL
TFIIB	NULL
in	NULL
vitro	NULL
(	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
identification	NULL
of	NULL
this	NULL
novel	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
IL-2Ra	NULL
promoter	NULL
further	NULL
elucidates	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
operate	NULL
to	NULL
ensure	NULL
the	NULL
precise	NULL
expression	NULL
of	NULL
the	NULL
high-affinity	NULL
IL-2	NULL
receptor	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Roy	NULL
Pollock	NULL
,	NULL
Brian	NULL
Safer	NULL
,	NULL
Robert	NULL
Adelstein	NULL
,	NULL
and	NULL
Kuan-Teh	NULL
Jeang	NULL
for	NULL
critical	NULL
comments	NULL
;	NULL
Nancy	NULL
Rice	NULL
for	NULL
anti-p50	NULL
antiserum	NULL
and	NULL
the	NULL
c-Rel	NULL
cDNA	NULL
;	NULL
Narayan	NULL
Bhat	NULL
for	NULL
the	NULL
anti-Ets-2	NULL
antisera	NULL
;	NULL
Alex	NULL
Bassuk	NULL
for	NULL
pcDNA1	NULL
Elf	NULL
(	NULL
100-619	NULL
)	NULL
and	NULL
peDNA1	NULL
Elf	NULL
(	NULL
100-304	NULL
)	NULL
;	NULL
Bradley	NULL
Cobb	NULL
for	NULL
the	NULL
anti-Elf-1	NULL
monoclonal	NULL
antibody	NULL
;	NULL
Alain	NULL
Israel	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p50	NULL
)	NULL
cDNA	NULL
;	NULL
Richard	NULL
Treisman	NULL
for	NULL
the	NULL
SRF	NULL
cDNA	NULL
;	NULL
Craig	NULL
Rosen	NULL
for	NULL
the	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
cDNA	NULL
;	NULL
Mark	NULL
Nissen	NULL
for	NULL
the	NULL
HMG-I	NULL
agarose	NULL
beads	NULL
;	NULL
Takashi	NULL
Uchiyama	NULL
for	NULL
Kit-225	NULL
cells	NULL
;	NULL
Arthur	NULL
Weiss	NULL
for	NULL
Jurkat	NULL
E6.1	NULL
cells	NULL
;	NULL
I.	NULL
Miyoshi	NULL
for	NULL
MT-2	NULL
cells	NULL
;	NULL
Junji	NULL
Yudoi	NULL
for	NULL
YT	NULL
cells	NULL
;	NULL
and	NULL
Yumi	NULL
Imai	NULL
for	NULL
Cos-7	NULL
cells	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
an	NULL
NIH	NULL
grant	NULL
,	NULL
RO1	NULL
AI29673	NULL
,	NULL
to	NULL
JML	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
1987	NULL
.	NULL

Methylation	NULL
interference	NULL
assay	NULL
for	NULL
analysis	NULL
of	NULL
DNA-protein	NULL
interactions	NULL
,	NULL
p.	NULL
12.3.1-12.3.4	NULL
.	NULL

In	NULL
F.	NULL
M.	NULL
Ausubel	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
D.	NULL
D.	NULL
Moore	NULL
,	NULL
J.	NULL
G.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
,	NULL
vol	NULL
.	NULL

2	NULL
.	NULL

Greene	NULL
Publishing	NULL
Associates	NULL
,	NULL
New	NULL
York	NULL
.	NULL

2	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hoffman	NULL
,	NULL
H.	NULL
P.	NULL
Bogerd	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
chain	NULL
gene	NULL
:	NULL
regulatory	NULL
role	NULL
for	NULL
DNA-protein	NULL
interactions	NULL
flanking	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

1:83-92	NULL
.	NULL

3	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
M.	NULL
Siekevitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
same	NULL
inducible	NULL
nuclear	NULL
proteins	NULL
regulate	NULL
mitogen	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
alpha	NULL
gene	NULL
and	NULL
type	NULL
1	NULL
HIV	NULL
.	NULL

Cell	NULL
53:827-836	NULL
.	NULL

4	NULL
.	NULL

Brownell	NULL
,	NULL
E.	NULL
,	NULL
N.	NULL
Mittereder	NULL
,	NULL
and	NULL
N.	NULL
Rice	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
human	NULL
rel	NULL
proto-oncogene	NULL
cDNA	NULL
containing	NULL
an	NULL
Alu	NULL
fragment	NULL
as	NULL
a	NULL
potential	NULL
coding	NULL
exon	NULL
.	NULL

Oncogene	NULL
4:935-942	NULL
.	NULL

5	NULL
.	NULL

Carlsson	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
L	NULL
Waterman	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
hLEF/TCF-1a	NULL
HMG	NULL
protein	NULL
contains	NULL
a	NULL
context-dependent	NULL
transcriptional	NULL
activation	NULL
domain	NULL
that	NULL
induces	NULL
the	NULL
TCRa	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2418-2430	NULL
.	NULL

6	NULL
.	NULL

Clevers	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
M.	NULL
A.	NULL
Oosterwegel	NULL
,	NULL
and	NULL
K.	NULL
Georgopoulos	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
factors	NULL
in	NULL
early	NULL
T-cell	NULL
development	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14:501-506	NULL
.	NULL

7	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Wolf	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
chain	NULL
gene	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
nonfunctional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-I	NULL
.	NULL

Cell	NULL
49:47-56	NULL
.	NULL

8	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
N.	NULL
F.	NULL
Halden	NULL
,	NULL
M.	NULL
J.	NULL
Lenardo	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1989	NULL
.	NULL

Functionally	NULL
distinct	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
Ig	NULL
x	NULL
and	NULL
IL-2	NULL
receptor	NULL
a	NULL
chain	NULL
genes	NULL
.	NULL

Science	NULL
244:466-469	NULL
.	NULL

9	NULL
.	NULL

Dalton	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
SAP-1	NULL
,	NULL
a	NULL
protein	NULL
recruited	NULL
by	NULL
serum	NULL
response	NULL
factor	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Cell	NULL
68:597-612	NULL
.	NULL

10	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

11	NULL
.	NULL

Disney	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
K.	NULL
R.	NULL
Johnson	NULL
,	NULL
N.	NULL
S.	NULL
Magnuson	NULL
,	NULL
S.	NULL
R.	NULL
Sylvester	NULL
,	NULL
and	NULL
R.	NULL
Reeves	NULL
.	NULL

1989	NULL
.	NULL

High-mobility	NULL
group	NULL
protein	NULL
HMG-I	NULL
localizes	NULL
to	NULL
G/Q-	NULL
and	NULL
C-bands	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
chromosomes	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

109:1975-1982	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

IL-2R	NULL
«	NULL
EXPRESSION	NULL
1795	NULL
Du	NULL
,	NULL
W.	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1993	NULL
.	NULL

Mechanisms	NULL
of	NULL
transcriptional	NULL
synergism	NULL
between	NULL
distinct	NULL
virus-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
74:887-898	NULL
.	NULL

Dudek	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
V.	NULL
Tantravahi	NULL
,	NULL
V.	NULL
N.	NULL
Rao	NULL
,	NULL
E.	NULL
S.	NULL
P.	NULL
Reddy	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
Reddy	NULL
.	NULL

1992	NULL
.	NULL

Myb	NULL
and	NULL
Ets	NULL
proteins	NULL
cooperate	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
mim-1	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1291-1295	NULL
.	NULL

Elton	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Reeves	NULL
.	NULL

1986	NULL
.	NULL

Purification	NULL
and	NULL
post-synthetic	NULL
modifications	NULL
of	NULL
Friend	NULL
erythroleukemic	NULL
cell	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
HMG-I	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

157:53-62	NULL
.	NULL

Evan	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
G.	NULL
K.	NULL
Lewis	NULL
,	NULL
G.	NULL
Ramsay	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Bishop	NULL
.	NULL

1985	NULL
.	NULL

Isolation	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
human	NULL
e-myc	NULL
proto-oncogene	NULL
product	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

5:3610-3616	NULL
.	NULL

Fashena	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
and	NULL
N.	NULL
H.	NULL
Ruddle	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
poly	NULL
(	NULL
dA-dT	NULL
)	NULL
upstream	NULL
activating	NULL
sequence	NULL
binds	NULL
high-mobility	NULL
group	NULL
I	NULL
protein	NULL
and	NULL
contributes	NULL
to	NULL
lymphotoxin	NULL
(	NULL
tumor	NULL
necrosis	NULL
factor-B	NULL
)	NULL
gene	NULL
regulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:894-903	NULL
.	NULL

Friedmann	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
T.	NULL
Holth	NULL
,	NULL
H.	NULL
Y.	NULL
Zoghbi	NULL
,	NULL
and	NULL
R.	NULL
Reeves	NULL
.	NULL

1993	NULL
.	NULL

Organiza-tion	NULL
,	NULL
inducible-expression	NULL
chromosome	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
nonhistone	NULL
protein	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:4259-4267	NULL
.	NULL

Fujiwara	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Koizumi	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
and	NULL
T.	NULL
Papas	NULL
.	NULL

1990	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
ETS-2	NULL
protein	NULL
:	NULL
regulation	NULL
by	NULL
the	NULL
T-cell	NULL
antigen	NULL
re-ceptor-CD3	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1249-1253	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Cox	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
HMG	NULL
domain	NULL
of	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
1	NULL
bends	NULL
DNA	NULL
and	NULL
facilitates	NULL
assembly	NULL
of	NULL
functional	NULL
nucleoprotein	NULL
structures	NULL
.	NULL

Cell	NULL
69:185-196	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1993	NULL
.	NULL

LEF-1	NULL
contains	NULL
an	NULL
activation	NULL
domain	NULL
that	NULL
stimulates	NULL
transcription	NULL
only	NULL
in	NULL
a	NULL
specific	NULL
context	NULL
of	NULL
factor-binding	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4667-4676	NULL
.	NULL

Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
M.	NULL
Ahdich	NULL
,	NULL
J.	NULL
Eisenman	NULL
,	NULL
K.	NULL
Shanebeck	NULL
,	NULL
K.	NULL
Grabstein	NULL
,	NULL
S.	NULL
Kumaki	NULL
,	NULL
A.	NULL
Namen	NULL
,	NULL
L.	NULL
S.	NULL
Park	NULL
,	NULL
D.	NULL
Cosman	NULL
,	NULL
and	NULL
D.	NULL
Anderson	NULL
.	NULL

1994	NULL
.	NULL

Utilization	NULL
of	NULL
the	NULL
B	NULL
and	NULL
y	NULL
chains	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
by	NULL
the	NULL
novel	NULL
cytokine	NULL
IL-15	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:2822-2830	NULL
.	NULL

Gottschalk	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
D.	NULL
M.	NULL
Giannola	NULL
,	NULL
and	NULL
S.	NULL
G.	NULL
Emerson	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
:	NULL
inducible	NULL
T	NULL
cell-restricted	NULL
expression	NULL
requires	NULL
intact	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1681-1692	NULL
.	NULL

Grossched	NULL
]	NULL
,	NULL
R.	NULL
,	NULL
K.	NULL
Giese	NULL
,	NULL
and	NULL
J.	NULL
Pagel	NULL
.	NULL

1994	NULL
.	NULL

HMG	NULL
domain	NULL
proteins	NULL
:	NULL
architectural	NULL
elements	NULL
in	NULL
the	NULL
assembly	NULL
of	NULL
nucleoprotein	NULL
structures	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

10:94-100	NULL
.	NULL

Gunther	NULL
,	NULL
C.	NULL
V.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Nye	NULL
,	NULL
R.	NULL
S.	NULL
Bryner	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Graves	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
proto-oncoprotein	NULL
Ets-1	NULL
defines	NULL
a	NULL
transcriptional	NULL
activator	NULL
sequence	NULL
within	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
the	NULL
Moloney	NULL
murine	NULL
sarcoma	NULL
virus	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:667-679.	NULL
.	NULL

Hatakeyama	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Tsudo	NULL
,	NULL
S.	NULL
Minamoto	NULL
,	NULL
T.	NULL
Kono	NULL
,	NULL
T.	NULL
Doi	NULL
,	NULL
T.	NULL
Miyata	NULL
,	NULL
M.	NULL
Miyasaka	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1989	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
B	NULL
chain	NULL
gene	NULL
:	NULL
generation	NULL
of	NULL
three	NULL
receptor	NULL
forms	NULL
by	NULL
cloned	NULL
human	NULL
«	NULL
and	NULL
B	NULL
cDNAs	NULL
.	NULL

Science	NULL
244:551-556	NULL
.	NULL

Henry	NULL
,	NULL
C.	NULL
1980	NULL
.	NULL

Cell	NULL
separation	NULL
,	NULL
p.	NULL
182-185	NULL
.	NULL

In	NULL
B	NULL
.	NULL

B.	NULL
Mishell	NULL
and	NULL
S.	NULL
M.	NULL
Shiigi	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Selected	NULL
methods	NULL
in	NULL
cellular	NULL
immunology	NULL
.	NULL

W.	NULL
H.	NULL
Freeman	NULL
,	NULL
San	NULL
Fran-cisco	NULL
.	NULL

Hipskind	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
V.	NULL
N.	NULL
Rao	NULL
,	NULL
C.	NULL
G.	NULL
Mueller	NULL
,	NULL
E.	NULL
S.	NULL
P.	NULL
Reddy	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1991	NULL
.	NULL

Ets-related	NULL
protein	NULL
Elk-1	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
c-fos	NULL
regulatory	NULL
factor	NULL
p62	NULL
``	NULL
C	NULL
``	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
354:531-534	NULL
.	NULL

Ho	NULL
,	NULL
L-C.	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
L.	NULL
R.	NULL
Gottschalk	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
C.	NULL
B.	NULL
Thomp	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1990	NULL
.	NULL

Sequence-specific	NULL
binding	NULL
of	NULL
human	NULL
Ets-1	NULL
to	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
a	NULL
gene	NULL
enhancer	NULL
.	NULL

Science	NULL
250:814-818	NULL
.	NULL

Ishida	NULL
,	NULL
N.	NULL
,	NULL
H.	NULL
Kanamori	NULL
,	NULL
T.	NULL
Noma	NULL
,	NULL
T.	NULL
Nikaido	NULL
,	NULL
H.	NULL
Sabe	NULL
,	NULL
N.	NULL
Suzuki	NULL
,	NULL
A.	NULL
Shimizu	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1985	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
structure	NULL
of	NULL
human	NULL
interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

13:7579-7589	NULL
.	NULL

Johnson	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
D.	NULL
A.	NULL
Lehn	NULL
,	NULL
and	NULL
R.	NULL
Reeves	NULL
.	NULL

1989	NULL
.	NULL

Alternative	NULL
processing	NULL
of	NULL
mRNAs	NULL
encoding	NULL
mammalian	NULL
chromosomal	NULL
high-mobility-group	NULL
proteins	NULL
HMG-I	NULL
and	NULL
HMG-Y	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:2114-2123	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuverle	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
M.	NULL
Higuchi	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
T.	NULL
Sudo	NULL
,	NULL
S.-I	NULL
.	NULL

Nish-ikawa	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
participation	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
y	NULL
chain	NULL
in	NULL
IL-7	NULL
receptor	NULL
complexes	NULL
.	NULL

Science	NULL
364:1453-1454	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Takeshita	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
S.	NULL
Watanabe	NULL
,	NULL
K.-L.	NULL
Arai	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1993	NULL
.	NULL

Sharing	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
y	NULL
chain	NULL
between	NULL
receptors	NULL
for	NULL
IL-2	NULL
and	NULL
IL-4	NULL
.	NULL

Science	NULL
272:1874-1877	NULL
.	NULL

Lai	NULL
,	NULL
J.-S.	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1992	NULL
.	NULL

Ethidium	NULL
bromide	NULL
provides	NULL
a	NULL
simple	NULL
tool	NULL
for	NULL
identifying	NULL
genuine	NULL
DNA-independent	NULL
protein	NULL
associations	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:6958-6962	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
J.	NULL
Mitchell	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Purified	NULL
transcription	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
49:741-752	NULL
.	NULL

Lehn	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
T.	NULL
S.	NULL
Elton	NULL
,	NULL
K.	NULL
R.	NULL
Johnson	NULL
,	NULL
and	NULL
R.	NULL
Reeves	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
conforma-tional	NULL
study	NULL
of	NULL
the	NULL
sequence	NULL
specific	NULL
binding	NULL
of	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
with	NULL
the	NULL
bovine	NULL
interleukin	NULL
2	NULL
cDNA	NULL
.	NULL

Biochem	NULL
.	NULL

Int	NULL
.	NULL

16:963-971	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
Ets-related	NULL
transcription	NULL
factor	NULL
,	NULL
Elf-1	NULL
,	NULL
binds	NULL
1796	NULL
38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

JOHN	NULL
ET	NULL
AL	NULL
.	NULL

to	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
regulatory	NULL
elements	NULL
that	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
frens	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5890-5897	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
receptor	NULL
;	NULL
structure	NULL
,	NULL
function	NULL
,	NULL
intra-cellular	NULL
messengers	NULL
and	NULL
molecular	NULL
regulation	NULL
,	NULL
p.	NULL
29-46	NULL
.	NULL

In	NULL
J.	NULL
Waxman	NULL
and	NULL
F.	NULL
Balkwill	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Interleukin-2	NULL
.	NULL

Blackwell	NULL
Scientific	NULL
Publications	NULL
Ltd.	NULL
,	NULL
Oxford	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
J.	NULL
M.	NULL
Depper	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
S.	NULL
Rudikoff	NULL
,	NULL
J.	NULL
Pumphrey	NULL
,	NULL
R.	NULL
J.	NULL
Robb	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
P.	NULL
B.	NULL
Svetlik	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
T.	NULL
A.	NULL
Waldmann	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1984	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
cDNAs	NULL
for	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
311:625-631	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
J.	NULL
M.	NULL
Depper	NULL
,	NULL
M.	NULL
Kanehisa	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
P.	NULL
B.	NULL
Svetlik	NULL
,	NULL
M.	NULL
Sullivan	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1985	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
gene	NULL
.	NULL

Science	NULL
230:633-639	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
M.	NULL
Kronke	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
J.	NULL
M.	NULL
Depper	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1985	NULL
.	NULL

Interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
expression	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:6281-6285	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
S.	NULL
M.	NULL
Russell	NULL
,	NULL
and	NULL
O.	NULL
W.	NULL
McBride	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
of	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
:	NULL
the	NULL
role	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
y	NULL
chain	NULL
as	NULL
a	NULL
common	NULL
y	NULL
chain	NULL
,	NULL
y	NULL
,	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

138:61-86	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-I	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:776-778	NULL
.	NULL

Lin	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
S.	NULL
L.	NULL
Cross	NULL
,	NULL
N.	NULL
F.	NULL
Halden	NULL
,	NULL
D.	NULL
G.	NULL
Roman	NULL
,	NULL
M.	NULL
B.	NULL
Toledano	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1990	NULL
.	NULL

Delineation	NULL
of	NULL
an	NULL
enhancerlike	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:850-853	NULL
.	NULL

Lin	NULL
,	NULL
J.~X	NULL
.	NULL

,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
S.	NULL
John	NULL
,	NULL
W.	NULL
S.	NULL
Queale	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
B-chain	NULL
gene	NULL
promoter	NULL
:	NULL
regulation	NULL
of	NULL
promoter	NULL
activity	NULL
by	NULL
ets	NULL
gene	NULL
products	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6201-6210	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
kB-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin	NULL
2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2331-2335	NULL
.	NULL

Lucknow	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
G.	NULL
Schutz	NULL
.	NULL

1987	NULL
.	NULL

CAT	NULL
constructions	NULL
with	NULL
multiple	NULL
unique	NULL
restriction	NULL
sites	NULL
for	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
and	NULL
regulatory	NULL
elements	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:5490	NULL
.	NULL

Lund	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Holtlund	NULL
,	NULL
M.	NULL
Fredricksen	NULL
,	NULL
and	NULL
S.	NULL
G.	NULL
Laland	NULL
.	NULL

1983	NULL
.	NULL

On	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
new	NULL
high	NULL
mobility	NULL
group-like	NULL
proteins	NULL
in	NULL
HeLaS3	NULL
cells	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

152:163-167	NULL
.	NULL

Macleod	NULL
,	NULL
K.	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

17:251-256	NULL
.	NULL

Maekawa	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Sakura	NULL
,	NULL
C.	NULL
Kanei-Ishii	NULL
,	NULL
T.	NULL
Sudo	NULL
,	NULL
T.	NULL
Yoshimura	NULL
,	NULL
J.-L.	NULL
Fuji-sawa	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
S.	NULL
Ishii	NULL
.	NULL

1989	NULL
.	NULL

Leucine	NULL
zipper	NULL
structure	NULL
of	NULL
the	NULL
protein	NULL
CRE-BP1	NULL
binding	NULL
to	NULL
the	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
in	NULL
brain	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:2023-2028	NULL
.	NULL

Mikaelian	NULL
,	NULL
L	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Sergeant	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
general	NULL
and	NULL
fast	NULL
method	NULL
to	NULL
generate	NULL
multiple	NULL
site	NULL
directed	NULL
mutations	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:376	NULL
.	NULL

Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
M.	NULL
Russell	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

Mess	NULL
,	NULL
M.	NULL
Friedmann	NULL
,	NULL
M.	NULL
Erdos	NULL
,	NULL
C.	NULL
Francois	NULL
,	NULL
Y.	NULL
Jacques	NULL
,	NULL
S.	NULL
Adelstein	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1994	NULL
.	NULL

Heterodimer-ization	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
B-	NULL
and	NULL
y-chain	NULL
cytoplasmic	NULL
domains	NULL
is	NULL
required	NULL
for	NULL
signaling	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
369:330-333	NULL
.	NULL

Nelson	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
J.	NULL
D.	NULL
Lord	NULL
,	NULL
and	NULL
P.	NULL
D.	NULL
Greenberg	NULL
.	NULL

1994	NULL
.	NULL

Cytoplasmic	NULL
domains	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
B	NULL
and	NULL
:	NULL
y	NULL
chains	NULL
mediate	NULL
the	NULL
signal	NULL
for	NULL
T-cell	NULL
proliferation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
369:333-336	NULL
.	NULL

Nikaido	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Shimizu	NULL
,	NULL
N.	NULL
Ishida	NULL
,	NULL
H.	NULL
Sabe	NULL
,	NULL
K.	NULL
Teshigawara	NULL
,	NULL
M.	NULL
Maeda	NULL
,	NULL
T.	NULL
Uchiyama	NULL
,	NULL
J.	NULL
Yodoi	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1984	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
cDNA	NULL
encoding	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
311:631-635	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Y.	NULL
Nakamura	NULL
,	NULL
S.	NULL
M.	NULL
Russell	NULL
,	NULL
S.	NULL
F.	NULL
Ziegler	NULL
,	NULL
M.	NULL
Tsang	NULL
,	NULL
X.	NULL
Cao	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
:	NULL
y	NULL
chain	NULL
:	NULL
a	NULL
functional	NULL
component	NULL
of	NULL
the	NULL
interleukin-7	NULL
receptor	NULL
.	NULL

Science	NULL
262:1877-1880	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Yi	NULL
,	NULL
H.	NULL
M.	NULL
Rosenblatt	NULL
,	NULL
A.	NULL
M.	NULL
Filipovich	NULL
,	NULL
S.	NULL
Adelstein	NULL
,	NULL
W.	NULL
S.	NULL
Modi	NULL
,	NULL
O.	NULL
W.	NULL
McBride	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
y	NULL
chain	NULL
mutation	NULL
results	NULL
in	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
in	NULL
humans	NULL
.	NULL

Cell	NULL
73:147-157	NULL
.	NULL

Norman	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Runswick	NULL
,	NULL
R.	NULL
Pollock	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1988	NULL
.	NULL

Isolation	NULL
and	NULL
properties	NULL
of	NULL
cDNA	NULL
clones	NULL
encoding	NULL
SRF	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
c-fos	NULL
serum	NULL
response	NULL
element	NULL
.	NULL

Cell	NULL
55:989-1003	NULL
.	NULL

Radic	NULL
,	NULL
M.	NULL
Z.	NULL
,	NULL
M.	NULL
Saghbini	NULL
,	NULL
T.	NULL
S.	NULL
Elton	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
and	NULL
B	NULL
.	NULL

A.	NULL
Hamkalo	NULL
.	NULL

1992	NULL
.	NULL

Hoecht	NULL
33258	NULL
,	NULL
distamycin	NULL
A	NULL
and	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
I	NULL
(	NULL
HMG-I	NULL
)	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
mouse	NULL
satellite	NULL
DNA	NULL
.	NULL

Chromosoma	NULL
101:602-608	NULL
.	NULL

Reeves	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Nissen	NULL
.	NULL

1993	NULL
.	NULL

Interaction	NULL
of	NULL
high	NULL
mobility	NULL
group-I	NULL
(	NULL
Y	NULL
)	NULL
60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

nonhistone	NULL
proteins	NULL
with	NULL
nucleosome	NULL
particles	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:21137-21146	NULL
.	NULL

Roman	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
M.	NULL
B.	NULL
Toledano	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1990	NULL
.	NULL

Sp1	NULL
represses	NULL
the	NULL
IL-2	NULL
receptor	NULL
«	NULL
chain	NULL
gene	NULL
expression	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

2:642-647	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cNDA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-kB	NULL
.	NULL

Science	NULL
251	NULL
:	NULL
1490-1493	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
A.	NULL
D.	NULL
Keegan	NULL
,	NULL
N.	NULL
Harada	NULL
,	NULL
Y.	NULL
Nakamura	NULL
,	NULL
M.	NULL
Noguchi	NULL
,	NULL
P.	NULL
Leland	NULL
,	NULL
M.	NULL
C.	NULL
Friedmann	NULL
,	NULL
A.	NULL
Miyajima	NULL
,	NULL
R.	NULL
Puri	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Interleukin-2	NULL
receptor	NULL
:	NULL
y	NULL
chain	NULL
:	NULL
a	NULL
functional	NULL
component	NULL
of	NULL
the	NULL
interleukin-4	NULL
receptor	NULL
.	NULL

Science	NULL
262:1880-1883	NULL
.	NULL

Seth	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Ascione	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
G.	NULL
J.	NULL
Mavrothalassitis	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ets	NULL
gene	NULL
family	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

3:327-334	NULL
.	NULL

Sharon	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
D.	NULL
Klausner	NULL
,	NULL
B.	NULL
R.	NULL
Cullen	NULL
,	NULL
R.	NULL
Chizzonite	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1986	NULL
.	NULL

Novel	NULL
interleukin-2	NULL
receptor	NULL
subunit	NULL
detected	NULL
by	NULL
cross-linking	NULL
under	NULL
high	NULL
affinity	NULL
conditions	NULL
.	NULL

Science	NULL
234:859-863	NULL
.	NULL

Sompayrac	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
K.	NULL
J.	NULL
Danna	NULL
.	NULL

1981	NULL
.	NULL

Efficient	NULL
infection	NULL
of	NULL
monkey	NULL
cells	NULL
with	NULL
DNA	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
78:7575-7578	NULL
.	NULL

Sturm	NULL
,	NULL
R.	NULL
,	NULL
T.	NULL
Baumruker	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
Herr	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
100	NULL
kD	NULL
Hela	NULL
cell	NULL
octamer	NULL
binding	NULL
protein	NULL
(	NULL
OBP	NULL
100	NULL
)	NULL
interacts	NULL
differently	NULL
with	NULL
two	NULL
separate	NULL
octamer-related	NULL
sequences	NULL
within	NULL
the	NULL
SV40	NULL
enhancer	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1:1147-1160	NULL
.	NULL

Suzuki	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Matsunami	NULL
,	NULL
H.	NULL
Kanamori	NULL
,	NULL
N.	NULL
Ishida	NULL
,	NULL
A.	NULL
Shimizu	NULL
,	NULL
Y.	NULL
Yavita	NULL
,	NULL
T.	NULL
Nikaido	NULL
,	NULL
and	NULL
T.	NULL
Honjo	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
human	NULL
IL-2	NULL
receptor	NULL
gene	NULL
contains	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
that	NULL
functions	NULL
in	NULL
cultured	NULL
cells	NULL
and	NULL
cell-free	NULL
extracts	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262:5079-5086	NULL
.	NULL

Takeshita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Asao	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
N.	NULL
Ishii	NULL
,	NULL
S.	NULL
Kumaki	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Munakata	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
y	NULL
chain	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
receptor	NULL
.	NULL

Science	NULL
257:379-382	NULL
.	NULL

Tan	NULL
,	NULL
T.-H.	NULL
,	NULL
G.	NULL
P.	NULL
Huang	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
P.	NULL
Ghosh	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
and	NULL
N.	NULL
R.	NULL
Rice	NULL
.	NULL

1992	NULL
.	NULL

«	NULL
B	NULL
site-dependent	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a-chain	NULL
gene	NULL
promoter	NULL
by	NULL
human	NULL
c-Rel	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4067-4075	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Y.	NULL
Minami	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
IL-2/IL-2	NULL
receptor	NULL
system	NULL
:	NULL
a	NULL
current	NULL
overview	NULL
.	NULL

Cell	NULL
73:5-8	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
is	NULL
required	NULL
for	NULL
NF-kappa	NULL
B-dependent	NULL
virus	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
IFN-beta	NULL
gene	NULL
.	NULL

Cell	NULL
71:777-789	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
C.-¥	NULL
.	NULL

Wang	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
P.	NULL
R.	NULL
Bobjanen	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Miesfeldt	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
B.	NULL
Karpinski	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992.	NULL
cis-acting	NULL
sequences	NULL
required	NULL
for	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
Ets-related	NULL
protein	NULL
,	NULL
Elf-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1043-1053	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Convergence	NULL
of	NULL
Ets-	NULL
and	NULL
Notch-related	NULL
structural	NULL
motifs	NULL
in	NULL
a	NULL
heteromeric	NULL
DNA	NULL
binding	NULL
complex	NULL
.	NULL

Science	NULL
253:762-768	NULL
.	NULL

Tjian	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1994	NULL
.	NULL

Transcriptional	NULL
activation	NULL
:	NULL
a	NULL
complex	NULL
puzzle	NULL
with	NULL
few	NULL
casy	NULL
pieces	NULL
.	NULL

Cell	NULL
77:5-8	NULL
.	NULL

Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
D.	NULL
G.	NULL
Roman	NULL
,	NULL
N.	NULL
F.	NULL
Halden	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
Lin	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
same	NULL
target	NULL
sequences	NULL
are	NULL
differentially	NULL
important	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
in	NULL
two	NULL
distinct	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1830-1834	NULL
.	NULL

Tsudo	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
W.	NULL
Kozak	NULL
,	NULL
C.	NULL
K.	NULL
Goldman	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Waldmann	NULL
.	NULL

1986	NULL
.	NULL

Demonstration	NULL
of	NULL
a	NULL
non-Tac	NULL
peptide	NULL
that	NULL
binds	NULL
interleukin-2	NULL
:	NULL
a	NULL
potential	NULL
participant	NULL
in	NULL
a	NULL
multichain	NULL
interleukin-2	NULL
receptor	NULL
complex	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:9694-9698	NULL
.	NULL

Urness	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
and	NULL
C.	NULL
S.	NULL
Thummel	NULL
.	NULL

1990	NULL
.	NULL

Molecular	NULL
interactions	NULL
within	NULL
the	NULL
ecydysone	NULL
regulatory	NULL
hierarchy	NULL
:	NULL
DNA	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
Drosophila	NULL
ecydysone-inducible	NULL
E74A	NULL
protein	NULL
.	NULL

Cell	NULL
63:47-61	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
A.	NULL
G.	NULL
Bassuk	NULL
,	NULL
L.	NULL
H.	NULL
Boise	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
requires	NULL
cooperative	NULL
binding	NULL
of	NULL
Elf-1	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1153-1159	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
B.	NULL
Petryniak	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992	NULL
.	NULL

Evolutionarily	NULL
conserved	NULL
Ets	NULL
family	NULL
members	NULL
display	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificities	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1391-1399	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
C.	NULL
Wasylyk	NULL
,	NULL
P.	NULL
Flores	NULL
,	NULL
A.	NULL
Begue	NULL
,	NULL
D.	NULL
Leprince	NULL
,	NULL
and	NULL
D.	NULL
Stehelin	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
c-ets	NULL
proto-oncogenes	NULL
encode	NULL
transcription	NULL
factors	NULL
that	NULL
cooperate	NULL
with	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346	NULL
:	NULL
191-193	NULL
.	NULL

Wurster	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
G.	NULL
Siu	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
$	NULL
.	NULL

M.	NULL
Hedrick	NULL
.	NULL

1994	NULL
.	NULL

Elf-1	NULL
binds	NULL
to	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
a	NULL
second	NULL
CD4	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6452-6463	NULL
.	NULL

